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Brown adipose tissue, comprising classical brown and beige adipocytes, holds 
therapeutic and diagnostic promise for the treatment of diabetes and metabolic 
syndrome. Key to realizing this potential is the ability to generate functional human 
brown adipocytes from a readily available and sustainable cell source. Here, I 
demonstrate the generation of a functional brown phenotype from adult human bone 
marrow-derived mesenchymal stem cells (bmMSCs) under macromolecular crowding 
(MMC), a biophysical principle applied to cell culture in order to mimic a more 
crowded in vivo environment by sterically excluding volume and speeding up the rate 
of extracellular matrix formation. Adipogenic differentiation of bmMSCs yielded 
substantial UCP1 expression only with the addition of Ficoll to generate MMC during 
the induction phase, indicating that adult human bmMSCs possess the intrinsic 
potential to undergo brown adipogenesis. The bmMSC-derived adipocytes generated 
under MMC were functionally capable of activating the thermogenic programme, 
which included the upregulation of thermogenic genes, lipolysis, mitochondrial 
membrane depolarisation, uncoupled respiration and increased oxygen consumption. 
Ficoll-induced MMC increased the deposition of collagen IV and heparan sulphate 
proteoglycans, indicative of a richer pro-adipogenic matrix, which through cell-
matrix reciprocity would drive adipogenesis of bmMSCs into a more mature 
phenotype. Additionally, bmMSC-derived white adipocytes could be ‘browned’ 
under MMC, suggesting that bmMSC-derived adipocytes or their precursor cells 
possess the plasticity to interconvert between white and brown. Moreover, there is 
preliminary data showing that the addition of Ficoll during adipogenic induction of 
progenitor cells isolated from the stromal vascular fraction also enhanced brown 
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adipogenesis, adding another potential sustainable cell source to the list. This study 
highlights the importance of the lineage-directing capacity of the microenvironment, 
which is enhanced under MMC. Interestingly Ficoll, may also enhance brown 
adipogenesis in bmMSC-derived adipocytes in an MMC-independent manner. 
Regardless, the relative ease of differentiating bmMSCs into the brown adipocyte 
phenotype (800-fold induction of UCP1 mRNA over white when stimulated) without 
the need for gene transfer or induced pluripotency unlocks the metabolic and 
therapeutic potential lying dormant in human bone marrow. I hereby report for the 
first time that adult human bmMSCs are a functional human brown adipocyte 
progenitor cell source comparable with other human brown adipocyte differentiation 
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CHAPTER 1: INTRODUCTION 
 
1.1 Global burden of obesity 
The ability to store excess energy efficiently has been evolutionarily advantageous to 
the survival of mankind as those who did were able to utilize these energy reserves to 
sustain themselves between meals when food was scarce. The human body has 
evolved to store excess energy in the form of fat (triglycerides) (Cinti, 2011), which 
has the highest energy-to-mass ratio as compared to other endogenous energy-bearing 
molecules such as carbohydrates (Da Poian et al., 2010); the cells specialized to store 
fat are the white adipocytes (Cinti, 2011). However, what was once a beneficial 
adaptation to cope with food scarcity has become a major health liability. Today 
presents an unnatural situation where food is abundant and easily accessible. Coupled 
with an increasingly sedentary lifestyle, the energy balance of an individual becomes 
upset, with energy intake far exceeding energy expenditure, leading to the condition 
of obesity (Bellisari, 2008). Obesity is defined as one’s Body Mass Index (BMI) ≥ 30 
kg/m2 (WHO, 2014) and of abnormal or excessive fat accumulation over a prolonged 
period which leads to multiple organ-specific pathological consequences (Lean, 
2010). According to the World Health Organisation, obesity rates have doubled since 
1980, causing obesity to reach epidemic proportions. Obesity affects more than 10% 
of the world’s adult population. Obesity and being overweight (BMI ≥ 25 kg/m2) are 
leading causes for global deaths. They are implicated in major disease burdens, such 
as 44% of diabetes, 23% of ischaemic heart disease and 7-41% of certain cancers. 
Obesity is a major risk factor for cardiovascular disease, metabolic syndrome and 
diabetes, osteoarthritis and cancer (endometrial, breast and colon) (WHO, 2014). 
Obesity is high in developed countries such as the United States of America and 
2 
 
Australia (WHO, 2008), but is also on the rise in low-income countries as well 
(WHO, 2014). In Singapore, the sharp rise in obesity prevalence from 6.9% in 2004 
to 10.8% in 2010 is a cause for worry (MOH, 2010). 
 
1.2 Obesity and disease 
The contribution of obesity in the etiology of disease is due to the dysfunction of 
white adipocytes in the progression of obesity. White adipose tissue (WAT) is not just 
a passive organ for storing and releasing fat; it is also an active endocrine organ, 
secreting adipokines such as leptin and adiponectin which regulate metabolism and 
satiety, as well as other peptides such as monocyte chemoattractant protein 1 (MCP1) 
and tumour necrosis factor α (TNFα) which have systemic effects on other organs. At 
the early stages of high calorific intake, the white adipocytes initially enlarge in size 
and actively store the excess triglycerides to maintain normal lipolytic rates during 
fasting periods. However, as adiposity increases, the white adipocytes are unable to 
cope with the prolonged high calorific load and enter into a pro-inflammatory state by 
secreting MCP1 and TNFα. This attracts the infiltration of macrophages and results in 
a chronic inflammation in WAT. The cytokines released during the inflammatory 
process alter white adipocyte metabolism greatly by decreasing triglyceride synthesis 
and insulin sensitivity to uptake glucose, and increasing the rate of lipolysis, resulting 
in increased levels of circulating free fatty acids (FFAs). Insulin sensitivity to uptake 
glucose decreases in muscle due to the overload of FFAs and the build-up of ectopic 
lipid droplets, as well as through the action of the secreted cytokines from WAT. This 
sets the foundation of the development of insulin resistance, metabolic syndrome and 
finally diabetes mellitus (Guilherme et al., 2008). Also the influx of FFAs and 
cytokines into the liver alters its metabolism greatly, leading to the increased 
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production of very low density lipoproteins (VLDL) and apolipoprotein B which 
increases the risk of atherosclerosis and cardiovascular disease. Hypertension also 
develops due to the increased blood volume in response to an increased body mass 
and blood viscosity. Stroke risk increases with hypertension and cardiovascular 
disease (Haslam and James, 2005). 
Despite an increased risk, some obese people do not progress to developing 
diabetes and other related diseases, suggesting other factors play a role in determining 
the severity of co-morbidity between obesity and disease. White adipose distribution, 
measured indirectly by waist-to-hip ratio, is a major risk indicator. Abdominal obesity 
is associated with an increased risk of diabetes and cardiovascular disease while 
subcutaneous obesity is not. This could be due to an unusually high influx of portal 
FFAs and cytokines from the omental adipocytes to the liver (Haslam and James, 
2005). Another reason could be that abdominal or visceral fat may possess a 
metabolic profile distinct from subcutaneous fat (Billon and Dani, 2012). Genetics 
also play a role in body fat distribution (Nelson et al., 2000) and the predisposition to 
obesity (Bell et al., 2005). Epigenetic imprinting of metabolic pathways during foetal 
life due to generations of malnutrition in utero, coupled to the recent abundance of 
food have been implicated to cause certain populations (India for example) to be 





1.3 Current treatment options for obesity 
Interventions aimed to treat obesity need to either reduce energy intake, increase 
energy expenditure, or both. Aside from exercise, practically all current interventions 
are aimed to reduce the energy intake side of the equation. Behavioural changes to 
adopt a more active physical lifestyle and healthier eating habits are hard to sustain 
for the long-term except for the very disciplined and committed individuals. 
Pharmacological interventions have met limited success due to undesirable side 
effects or inefficacy at curbing obesity in the long-term (Kim et al., 2014; Tseng et 
al., 2010). As of September 2013, there are only 3 drugs approved by the FDA for use 
as adjunctive therapy for chronic weight management: orlistat (Alli, 
GlaxoSmithKline; Xenical, Roche), phentermine/ topimerate extended release 
formulation (Qsymia, Vivus), and lorcaserin (Belviq, Arena Pharmaceuticals). These 
either act at the satiety centres in the brain (Qysmia and Belviq) or reduce systemic 
fat absorption from the intestine by inhibiting gastrointestinal lipases (Alli / Xenical) 
(Kim et al., 2014). Bariatric procedures have been proven more effective than 
lifestyle and medical interventions in reducing obesity but they are not without risks 
such as perioperative mortality and post-surgical complications (Arterburn and 
Courcoulas, 2014). Failure of these interventions to curb the rising trend of obesity by 
reducing energy intake is not surprising. The human body is designed to guard against 
starvation. When there is a decrease in food intake, the body’s homeostatic 
mechanisms kick in to conserve energy by decreasing its basal metabolic rate, thus 
making it even harder for further weight loss. Targeting energy expenditure presents a 
more attractive option, as increasing energy output may be able to reset the 
homeostatic threshold for body weight of an obese individual to a lower, healthier 
range (Tseng et al., 2010).  
5 
 
1.4 Brown adipose tissue and its unique function of non-shivering thermogenesis 
In addition to WAT, mammals possess another type of fat, known as brown adipose 
tissue (BAT). Although both have the ability to store lipids, the function of BAT is 
entirely different from that of WAT. The main function of BAT is the expenditure of 
energy to produce heat in response to environmental temperature or diet, a process 
known as non-shivering thermogenesis. It serves the purpose of protection against 
cold exposure as well as regulation of energy balance (Yoneshiro et al., 2011). The 
protein responsible for conferring BAT its thermogenic function is the uncoupling 
protein 1 (UCP1), a 32kDa transmembrane inner mitochondrial membrane protein 
specific to brown adipocytes. When activated, UCP1 uncouples ATP synthesis from 
the electrochemical proton gradient in the electron transport chain, thereby producing 
heat (Fig. 1.1). When activated, UCP1 provides a channel for protons to rush out from 
the inter-membrane space down its electrochemical gradient to the mitochondrial 
matrix without being coupled to ATP generation. Heat is generated by the dissipation 
of the inter-membrane proton-motive force, and indirectly by the increased activity of 





Figure 1.1. Uncoupling function of UCP1. Activated UCP1 residing in the inner 
mitochondrial membrane uncouples the proton gradient built up by the electron transport 
chain from ATP production, generating heat in the process. (Figure adapted from (Tseng et 
al., 2010). 
 
In mice, thermogenesis in brown adipocytes is activated by the sympathetic nervous 
system in response to cold exposure. Noradrenaline acts principally through the β-
adrenergic receptors, which leads to an increase in intracellular cyclic adenosine 
monophosphate (cAMP) levels. This in turn activates protein kinase A (PKA) and 
through multiple signalling transduction cascades drives thermogenesis. PKA 
stimulates gluconeogenesis and lipolysis, providing metabolic fuel for the 
mitochondria via the tricarboxylic acid cycle and β-oxidation respectively (Bonet et 
al., 2013; Tseng et al., 2010). Moreover, the free fatty acids (FFAs) produced upon 
lipolysis activate UCP1 by directly binding to UCP1 and removing the inhibitory 
effect of purine nucleotides (e.g. guanidine diphosphate) on UCP1 (Cannon and 
Nedergaard, 2004). Activation of PKA and its resulting downstream pathways lead to 
the phosphorylation of various transcription factors such as activating-transcription 
factor 2 (ATF2) and cAMP response element binding protein (CREB), which directly 
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induce UCP1 transcription. PKA also promotes the transcription of thermogenic 
genes such as deiodinase, iodothyronine, type II (DIO2) and PPARγ co-activator 1α 
(PGC1α). DIO2 converts thyroxine (T4) to its active form triiodothyronine (T3), 
which then activates UCP1 transcription through the thyroid hormone receptor. 
PGC1α is a co-factor which binds to other transcription factors to induce UCP1 
transcription. In addition, it also promotes mitochondrial biogenesis to further 
increase the cell’s thermogenic capacity (Bonet et al., 2013). Besides noradrenaline, 
β-agonists like isoproterenol (Wang et al., 2008a), and pharmacologic agents which 
act on downstream targets to increase cAMP such as forskolin (Seale et al., 2008) and 
dibutyryl cAMP (Tseng et al., 2008) are used to induce the thermogenic programme 
in brown adipocytes, summarized in figure 1.2. Besides UCP1, other functional 





Figure 1.2. Activation of thermogenesis in brown adipocytes. Cold exposure, or 
pharmacological agents stimulate the β-adrenergic pathway which results in the activation of 
protein kinase A (PKA). PKA then initiates a cascade of events which lead to increase in 
metabolic fuel, mitochondrial biogenesis, UCP1 transcription and activity and ultimately an 
increase in thermogenesis. cAMP = cyclic AMP, FFA = free fatty acids, ATF2 = activating-
transcription factor 2, CREB = cAMP response element binding protein, DIO2 = deiodinase, 
iodothyronine, type II, PGC1α = PPARγ co-activator 1α, T3 = triiodothyronine, UCP1 = 
uncoupling protein 1. 





Table 1.1. Brown-selective markers. 
Factor Name Function Reference 
UCP1 Uncoupling 
protein 1 
Protein responsible for uncoupled 







Negatively regulates thermogenic 
function in brown fat, possibly by 
inhibiting UCP1.  






Transcription regulator controlling the 
stem cell fate between brown fat and 
skeletal muscle. 
(Kajimura et al., 
2009; Seale et al., 
2008) 
ELOVL3 Elongation of 
very long chain 
fatty acid 
elongase 3 
Involved in brown fat hyperplasia upon 
cold exposure or β-adrenergic 
stimulation, possibly due to the 
synthesis of saturated very long chain 
fatty acids in brown fat. 
(Tvrdik et al., 1997; 




Increase mitochondrial biogenesis and 
UCP1 transcription during cold 
exposure or β-adrenergic stimulation. 
(Bonet et al., 2013; 




Converts T4 to T3 during cold exposure 
or β-adrenergic stimulation, which then 
activates UCP1 transcription. 
(Bonet et al., 2013) 
 
1.5 Types of brown adipose tissue 
Emerging evidence suggests that brown adipocytes from different anatomical 
locations originate from different developmental lineages (Billon and Dani, 2012; 
Rosenwald and Wolfrum, 2014). At least two populations of brown adipocytes exist – 
the classical brown adipocytes and the beige adipocytes. Rodents possess a 
substantial amount of BAT in the interscapular region (Harms and Seale, 2013). The 
brown adipocytes from this depot are termed classical brown adipocytes which 
originated from cells that expressed myogenic factor 5 positive (myf5+) (Seale et al., 
2008) and paired box 7 (Pax7+) (Lepper and Fan, 2010). They are developmentally 
distinct from white adipocytes, but share a common progenitor with skeletal muscle. 
In vivo fate-mapping studies in mice embryos have shown that the myogenin-
expressing central dermomyotome gave rise not only to the dermis and skeletal 
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muscle, but also to interscapular BAT, suggesting that skeletal muscle and 
interscapular BAT share a common developmental pathway (Atit et al., 2006). In 
support of this notion, cultured brown adipocyte progenitors expressed a myogenic 
transcriptional signature, which included myogenin and myf5 (Timmons et al., 2007). 
In vivo lineage tracing studies in mice by (Seale et al., 2008) further confirmed that 
myf5+ expressing cells gave rise to BAT from the interscapular and peri-renal depots 
and skeletal muscle, but not to WAT. The existence of a common transcriptional 
programme for both BAT and skeletal muscle precursors was verified by discovering 
that PRD1-BF1-RIZ1 homologous domain containing 16 (PRDM16) functioned as a 
molecular switch to the BAT cell fate instead of skeletal muscle (Seale et al., 2008) 
through forming a transcriptional complex with CCAAT-enhancer binding protein β 
(C/EBPβ) (Kajimura et al., 2009). Through lineage tracing studies using endothelial 
marker (vascular endothelial) VE-cadherin, progenitors of classical brown adipocytes, 
like their white adipocyte counterparts, are found as perivascular cells in the 
capillaries of the respective depots (Gupta et al., 2012; Tran et al., 2012). 
Beige adipocytes are UCP1-expressing adipocytes that appear ectopically in 
WAT depots in response to cold-induced β-adrenergic stimulation (Guerra et al., 
1998) or chronic PPARγ (peroxisome proliferator-activated receptor gamma) agonist 
treatment (Petrovic et al., 2010; Vernochet et al., 2009). They are also known as 
“brown-in-white” / “brite” / “inducible-brown” adipocytes. The recruitment of beige 
adipocytes in a white adipose depot is known as “browning” (Bartelt and Heeren, 
2014). Lineage tracing studies showed that beige adipocytes found in epididymal 
(Seale et al., 2008) and inguinal (Sanchez-Gurmaches et al., 2012) WAT in mice 
were myf5-, indicating that they do not share the same myogenic origin as classical 
brown adipocytes. Interestingly, (Sanchez-Gurmaches et al., 2012) discovered a 
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subpopulation of white adipocytes that were derived from myf5+ progenitors, 
challenging the notion that only myf5+ precursors gave rise to muscle and classical 
brown adipocytes. The beige cells induced by chronic PPARγ agonist treatment using 
thiazolidinediones during differentiation of white adipocytes in mice are 
developmentally closer to white adipocytes than the classical brown population 
(Petrovic et al., 2010), although this phenotypic conversion represses a series of 
“visceral white fat” genes (Vernochet et al., 2009). The recruitment of beige 
adipocytes in WAT depots may occur either by de novo generation of precursor cells, 
or interconversion of white adipocytes into beige, a process known as 
transdifferentiation (Bartelt and Heeren, 2014). In mice epididymal WAT, both white 
adipocytes and brown adipocytes that appeared from prolonged β-adrenergic 
stimulation arose from the proliferation and differentiation of a population of 
bipotential progenitor cells that expressed platelet-derived growth factor receptor α 
(PDGFRα) (Lee et al., 2012). Progenitor cells from inguinal WAT were isolated, 
cloned and shown to be able to differentiate into beige cells with a molecular 
signature distinct from white and classical brown adipocytes (Wu et al., 2012). The 
notion of beige adipocytes appearing in WAT depots by transdifferentiation of white 
adipocytes has been suspected (Barbatelli et al., 2010; Cinti, 2009). But only recently 
through in vivo lineage tracing studies, it was shown that the beige adipocytes which 
appeared in mice inguinal WAT upon cold-stimulation were able to transdifferentiate 
into white adipocytes upon 5 weeks of warm adaptation, and convert back into beige 
adipocytes on additional cold stimulation (Rosenwald et al., 2013). Figure 1.3 





Figure 1.3. Developmental lineages of adipocytes. Figure reprinted from (Rosenwald 
and Wolfrum, 2014). [Permission is not required for reuse in a thesis/dissertation.] 
 
Besides differences in anatomical location and developmental origin, attempts 
have been made to establish a molecular signature to differentiate classical brown, 
beige and white adipocytes in mice. (Sharp et al., 2012) compared gene expression 
levels between differentiated cells from interscapular BAT (classical brown), inguinal 
WAT that has been exposed to rosiglitazone (beige) and inguinal WAT without 
rosiglitazone treatment (white). (Walden et al., 2012) carried out a more extensive 
analysis on multiple adipose depots in mice and categorised them into classical brown 
(interscapular, cervical, axillary, mediastinal BAT), beige (cardiac, inguinal, 
retroperitoneal WAT) and white (mesenteric, epididymal WAT) based on high, 
intermediumte and low levels of UCP1 expression, respectively. The approach of 
comparing different adipose depots has its limitations on distinguishing white from 
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beige adipocytes as inducible beige adipocytes exist even in the “white” epididymal 
adipose depot (Seale et al., 2008), suggesting that the depots that have been 
classically termed as “white” contain a heterogenous population of both white and 
beige adipocytes. To obtain a homogenous population of beige adipocytes, (Wu et al., 
2012) isolated progenitor cells from the stromal vascular fraction of mice inguinal 
adipose tissue and established different clonal populations. The cells were 
differentiated and treated with forskolin, and the mRNA was used for a gene array 
analysis. A subset of the clonal populations showed a significant increase in UCP1 
expression after a 4h forskolin stimulus, and displayed a molecular signature unique 
to the low UCP1-expressing clonal populations and interscapular BAT (classical 
brown control). However, this study did not report a white-selective marker panel. 




Table 1.2. Marker panel comparison of white, beige and classical brown 
adipocytes in mice. 
 
Adipocyte markers (Sharp et al., 2012) (Walden et al., 
2012) 







































Markers common to at least 2 studies are in bold. Agt = angiotensinogen, Wdnm1 = 
WDNM1-like protein, Fgf21 = fibroblast growth factor 21, Car4 = carbonic anhydrase 4, 
Cited1 = Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1, 
Hox9a = homeo box gene 9, Zic1 = zinc finger protein of the cerebellum 1, Lhx8 = LIM 
homeobox protein 8, Epstl1 = epithelial stromal interaction 1, Tcf21 = transcription factor 21, 
Hoxc9 = homeobox C9, Mylpf = myosin regulatory light chain, Klhl13 = kelch-like family 
member 13, Ear2 = eosinophil-associated, ribonuclease A family, member 2, Tmem26 = 
transmembrane protein 26, Tbx1 = T-box 1, Slc27a1 = solute carrier family 27 (fatty acid 
transporter), member 1, Eva1 = Epithelial V-Like Antigen 1, Fbxo31 = F-box protein 31, 
Pdk4 = pyruvate dehydrogenase kinase, isozyme 4, Acot2 = acyl-CoA thioesterase 2, Ebf3 = 
early B cell factor 3, Hspb7 = heat shock protein family, member 7, Slc29a1 = solute carrier 
family 29 (nucleoside transporters), member 1, Oplah = 5-oxoprolinase (ATP-hydrolysing). 
 
In addition, ectopic brown adipocytes and their progenitors have been 
identified in non-adipose tissue depots such as skeletal muscle (Almind et al., 2007; 
Schulz et al., 2011) as well.   
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1.6 Brown adipose tissue in adult humans 
BAT in humans, for a long time was assumed to exist in infants, primarily in the 
interscapular region (Fig. 1.4), and regressed in adulthood. Thus the importance and 
function of BAT was considered biologically irrelevant in adult humans. With the 
advent of positron-emission tomography in combination with computed tomography 
(PET/CT) to search for metabolically active tumours using 18F-fluorodeoxyglucose 
(18F-FDG) uptake, radiologists noted small, but distinct, non-tumour collections of 
adipose tissue (termed as “USA-fat”) with high uptake of this tracer (Cohade et al., 
2003). In 2007, a review by (Nedergaard et al., 2007) put forth the hypothesis from 
evidence accumulated from 18F-FDG PET/CT uptake studies, that BAT was present 
in adult humans in the neck and supraclavicular regions, as well as the mediastinum, 
paravertebral and suprarenal regions (Fig. 1.4). The presence of adult BAT inferred 
from these studies was suspected as early as 2002 (Hany et al., 2002), but only in 
2009 did five independent groups manage to show conclusively the presence of BAT 
in adult humans (Cypess et al., 2009; Saito et al., 2009; van Marken Lichtenbelt et al., 
2009; Virtanen et al., 2009; Zingaretti et al., 2009). Using 18F-FDG PET/CT uptake 
technique to locate these metabolically active depots under cold exposure (Fig. 1.4), 
fat biopsies were taken and tested positive for UCP1. The adipocytes also displayed a 





Figure 1.4. Distribution of BAT in newborns, infants in comparison to that in 
adults. (A) BAT in infants is located in the interscapular region, perirenal, mediastinal, in 
the neck region above and below the clavicles. (B) Schematic of BAT in cold-challenged 
adults via FDG-PET highlighting areas of high glucose uptake, a method originally used to 
detect tumors. (C) example of FDG-PET uptake in a morbidly obese female patient after cold 
challenge. Superimposition of CT and glucose PET. The supraclavicular and neck BAT 
patches are evident (Vijgen et al., 2011). [Figures B and C are reprinted from (Nedergaard et 
al., 2007) and (Vijgen et al., 2011). [Permission is not required for reuse in a 
thesis/dissertation.] 
 
In light of the recent studies in mice, various research groups have used the set 
of gene markers distinguishing between the white, beige and classical brown 
populations in mice on human samples in order to identify the type of BAT found in 
humans. Substantial amounts of classical brown adipocytes clustered in the 
interscapular region, but only during infancy (Lidell et al., 2013). The supraclavicular 
BAT region found in adults appeared to be composed mainly of beige adipocytes 
(Sharp et al., 2012; Wu et al., 2012), or a mixture of both beige and classical brown 
adipocytes (Cypess et al., 2013; Jespersen et al., 2013). Table 1.3 summarizes the 
gene marker panel analysis reported from these five studies. There are some 
discrepancies between mice and human studies, e.g. homeobox C9 (HOXC9), a 
murine beige marker had the highest expression in the superficial WAT in neck 
region, as well as abdominal subcutaneous WAT, compared to the beige tissue 
counterparts (Cypess et al., 2013; Jespersen et al., 2013). There are also variations 
between human studies, e.g. there was no difference in expression of epithelial V-
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Like antigen 1 (EVA1), a murine classical brown marker, between WAT and beige 
depots in (Sharp et al., 2012; Wu et al., 2012), but EVA1 had the highest expression in 
the superficial WAT neck region compared to deeper neck BAT (Cypess et al., 2013). 
Overall, there seems to be a consensus between the studies on some of the markers in 
humans that distinguish a) classical brown: zinc finger protein of the cerebellum 1 
(ZIC1) and LIM homeobox protein 8 (LHX8), b) beige markers: transmembrane 





Table 1.3. Marker panel comparison of white, beige and classical brown 




(Sharp et al., 
2012) 
(Wu et al., 
2012) 
(Lidell et al., 
2013) 

















































































Comments No difference 
between 





































Markers common to at least 2 studies are in bold. *Other BAT depots were used in the study 
but only supraclavicular BAT results are reflected in this table. TMEM26 = transmembrane 
protein 26, HOXC8 = homeobox C8, HOXC9 = homeobox C9, FGF21 = fibroblast growth 
factor 21, CITED1 = Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal 
domain 1, ZIC1 = zinc finger protein of the cerebellum 1, LHX8 = LIM homeobox protein 8, 
EPSTL1 = epithelial stromal interaction 1, TBX1 = T-box 1, EVA1 = epithelial V-Like antigen 
1, FBXO31 = F-box protein 31, EBF3 = early B cell factor 3, LEP = leptin, SHOX2 = short 
stature homeobox 2, miR-206 = mircroRNA 206.  
 
1.7 Brown adipose tissue as a target for obesity therapy 
It has been observed in mice that BAT and possibly the extent of browning of WAT 
play a significant role in resisting diet-induced obesity. Initially, studies in mice with 
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various models of genetically ablated BAT presented conflicting findings on 
increasing the susceptibility to obesity, with (Lowell et al., 1993) showing the 
development of obesity and insulin resistance in UCP1-ablated mice which also 
developed hyperphagia, while others showed that UCP1-ablated mice failed to 
develop an obese phenotype (Enerback et al., 1997; Liu et al., 2003). In 2009, 
Feldman and colleagues reconciled the conflicting views in literature by showing that 
UCP1-ablated mice only developed obesity when living at thermoneutrality (~30oC), 
which explains the earlier observations as typical housing conditions for mice were at 
~18-22oC, and served as a chronic thermal stress to the mice which in turn possibly 
influenced the outcome of those studies (Feldmann et al., 2009). When activated by 
the sympathetic nervous system, interscapular BAT becomes a fuel-guzzling organ in 
order to sustain thermogenesis in mice (Bartelt et al., 2011). As BAT lipolyses fat 
stores to FFAs to activate UCP1 and sustain mitochondrial activity through β-
oxidation, it also takes up triglycerides from the systemic circulation. Furthermore, it 
also acts as a glucose sink, taking up blood glucose to further sustain thermogenesis 
(Nedergaard et al., 2011).  
An early finding suggesting a possible link between the browning of WAT in 
resisting obesity in mice was reported in (Kopecky et al., 1995). Overexpression of 
UCP1 specific to adipocytes was performed using an aP2 gene promoter and 
particularly increased UCP1 expression in WAT. Obesity was reduced significantly 
in genetically obese Avy/+ mice expressing this transgene. Inbred mice from different 
genetic backgrounds had a differential capability of upregulating UCP1 in WAT but 
not in interscapular BAT, and there was a correlation between UCP1-expression in 
WAT and weight loss in response to β3-adrenergic stimulation (Guerra et al., 1998). 
Besides β-adrenergic stimuli and PPARγ agonists, other agents that cause browning 
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in WAT have been reported (Bonet et al., 2013). However, more research needs to be 
carried out to ascertain the true metabolic contribution of beige adipocytes in WAT 
during adaptive thermogenesis to assess its role in preventing diet-induced obesity 
(Bartelt and Heeren, 2014). 
In conjunction with previous estimates that in humans as little as 50g of 
maximally stimulated BAT could account for 20% of daily energy expenditure 
(Rothwell and Stock, 1983), an enormous therapeutic potential is currently ascribed 
to brown adipocytes or methods for browning WAT for tackling obesity and pertinent 
co-morbidities such as type 2 diabetes, and metabolic syndrome (Cypess and Kahn, 
2010). Yoneshiro et al. (2011) reported that in humans, after a 2h cold exposure, 
energy expenditure increased by about 28% in a group with detectable BAT and this 
correlated with increased BAT activity estimated by FDG-uptake into the neck and 
paravertebral regions, compared to a 3% increase in energy expenditure in the BAT-
negative group (Yoneshiro et al., 2011). In another study, upon cold exposure, there 
was an increased uptake of glucose and non-esterified fatty acids into supraclavicular 
BAT but not in adjoining skeletal muscles and subcutaneous adipose tissue, as well as 
increased BAT oxidative metabolism, and this was associated with an increased total 
energy expenditure probably to sustain thermogenesis in BAT (Ouellet et al., 2012). 
Moreover, the amount and activity of BAT are negatively correlated with BMI, age 
and diabetic status (Orava et al., 2013; Ouellet et al., 2011; van Marken Lichtenbelt et 
al., 2009), suggesting a causal link between decreased BAT activity and weight gain. 
As the amount of BAT in humans is typically quite low, the idea of increasing the 
amount of beige adipocytes through browning of existing WAT depots is also a very 
attractive option (Bartelt and Heeren, 2014). Therefore, a great demand for a 
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sustainable source of human classical brown / beige adipocytes for clinically relevant 
studies has arisen. 
 
1.8 The therapeutic and biotechnological gap – the need for progenitor cells 
There are 2 main approaches to utilise the thermogenic capacity of BAT as a 
treatment option for obesity – the ex vivo approach where functional BAT is 
generated in vitro from progenitor cells and then transplanted back into the patient as 
a cell therapy; and the in vivo approach where pharmacological agents or 
nutraceutical compounds are administered to the patient to increase differentiation 
and thermogenic activation of BAT (Tseng et al., 2010). As mentioned in section 1.3, 
current pharmacological interventions for use in chronic weight management have 
met limited success due to limited efficacy or safety concerns. Much of the anti-
obesity drug research targets have focused on regulating the neurological networks 
that control satiety. However, with the recent discovery of functional BAT in adult 
humans, there has been great interest in identifying pharmacological and nutraceutical 
compounds that target BAT differentiation and thermogenesis to increase energy 
expenditure as a strategy to counteract obesity. New pathways involving BAT 
differentiation and thermogenic activation are being unraveled, increasing the number 
of potential targets for pharmacological intervention (Villarroya and Vidal-Puig, 
2013). Dietary compounds such as capsinoids have been shown to increase energy 
expenditure in humans by activating BAT (Yoneshiro et al., 2012). Thus a human 
cell-based screening platform would be useful to identify promising pharmacological 
and nutraceutical targets (Dulloo, 2011). For the cell system to be used in the 
screening platform, primary human progenitor cells that can differentiate into 
functional brown adipocytes would provide a response more representative of the in 
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vivo condition as compared to immortalized or genetically modified cell lines (Ebert 
and Svendsen, 2010; Zang et al., 2012). In fact, some of the leading scientists in the 
brown fat field are involved in industry ventures to develop this screening platform 
capability, or for cell therapy (Table 1.4).  
 
Table 1.4. Scientists involved in biotechnology companies that are developing 
BAT screening platforms or for cell therapy. 
 












Bruce M Spiegelman  
C Ronald Kahn   
(Seale et al., 2008) 
(Tseng et al., 2008) 
 
However, given the anatomical location and amount of BAT in humans (see 
figure 1.4), the isolation of sufficient and sustainable numbers of human primary 
brown and beige adipocytes is problematic. Currently brown adipocyte differentiation 
protocols for human progenitor cells require the isolation of precursor cells from 
tissue locations difficult to attain (e.g. FDG/PET-positive BAT depots in humans), or 
require substantial reprogramming of starting material, or require precursor cells 
obtained from non-adult sources. Generating brown adipocytes through gene 
manipulation presents a major hurdle in translating the technology from bench to 
bedside. Attempts to obtain progenitor cells that can differentiate into brown 
adipocyte-like cells have been done from very young subjects or aborted foetuses, 
which do not represent a readily available, cost-effective, autologous, or ethically 
sound solution. Moreover, progenitor cells obtained from young subjects or foetal 
sources are not representative of BAT in adults as the type of BAT in infants and 
adults is different (Lidell et al., 2013). Therefore it is essential that a method for 
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generating human BAT from a readily available adult cell source be found in order to 
advance the field. The current human cell models of brown adipogenesis are reviewed 
in (Beranger et al., 2013), and summarised in table 1.5.  
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Table 1.5. Comparison of current in vitro human cellular models of brown 
adipogenesis. 
 
Cell model Functional efficiency  
(UCP1 mRNA 
upregulation) 
Pros and Cons Reference 
Progenitor cells 
from the SVF or 
preadipocytes of 
supraclavicular fat 
20-40 fold higher than 
subcut. WAT. 
 
60-fold higher than 
preadipocytes from 
subcut. abdominal WAT. 
Pros 
 Isolation of progenitor cells 
from an identified PET/FDG-
positive human BAT depot 
 Robust expression of UCP1 and 
response to cAMP stimuli 
Cons 
 Invasive harvest, hard to obtain 






from the SVF of 
neck fat 
5-fold upregulation in 








Upregulation of UCP1 
compared to non-induced 
cells. No fold change 
was reported. 
Pros 
 Isolation of progenitor cells 
from a possible human BAT 
depot 
Cons 
 Invasive harvest, hard to obtain 







Upregulation of UCP1 in 
thiazolidinedione-
differerentiated 
adipocytes compared to 
vehicle controls. No fold 
change was reported. 
Pros 
 Available cell source 
Cons 
 Browning effect not robust 
 No functional metabolic tests 
available 




stem cells isolated 
from biopsies of 
subcutaneous fat 
taken from the 
pubic region of 
infants and young 
children 
13-39 fold higher 
compared to treatment 
with rosiglitazone for 
only 3-9 days during 
differentiation (no UCP1 
expression but 
comparable expression of 
WAT genes). 
Pros 
 Robust expression of UCP1 and 
thermogenesis 
 Platform for white-to-brown 
conversion available 
Cons 
 Cell source not readily available 
 Non-adult source 
(Elabd et al., 
2009) 









either brown or 
white fat 
60-fold higher compared 
to another bone marrow 
sample. 
Pros 
 High expression of UCP1  
Cons 
 Cell source not readily available 
 Unpredictable – one donor 
source contained brown 
adipocytes whereas the other 
contained white adipocytes  
 Ethical issues 
 Non-adult source 
(Morganstein 
et al., 2010) 
Foetal muscle 
progenitor CD34+  
cells  
UCP1 mRNA levels a 
forth of mouse BAT.  
8-fold upregulation in 
response to cAMP 
stimulation. 
Pros 
 Novel cell source 
Cons 
 Cell source not readily available 
 Ethical issues 
 Non-adult source 





Cell model Functional efficiency  
(UCP1 mRNA 
upregulation) 
Pros and Cons Reference 
PAZ6 
Isolated from the 
SVF of infant BAT 
and immortalised 
using T and t 
SV40 antigens 
UCP1 mRNA was 
detected and increased 
upon NE stimulation. No 
fold change was 
reported. 
Pros 
 Cell line, easily obtainable 
Cons 
 No functional metabolic tests 
available 










compared to transduced 
“WAT”. 
Pros 
 Robust expression of UCP1 and 
thermogenesis 
Cons 












 Robust expression of UCP1 and 
thermogenesis 
Cons 











 Available cell source 
Cons 
 Genetically manipulated 
 Differentiation length was too 















 Available cell source 
Cons 
 Genetically manipulated 
(Tiraby et 
al., 2003) 
SVF = stromal vascular fraction, hMADS = human multipotent adipose-derived stem cells, 
bmMSCs = bone marrow mesenchymal stem cells, iPS = induced pluripotent stem cells, 





1.9 Macromolecular crowding, a novel cell culture platform that enhances 
adipogenic differentiation of adult human bone marrow mesenchymal stem cells 
via an enriched microenvironment 
It is recognized that in vitro monolayer culture conditions differ greatly from the in 
vivo tissue microenvironments from which the cells are derived (Abbott, 2003; 
Mazzoleni et al., 2009). A major limitation of 2D monolayer cultures is that they fail 
to capture the complexity of the in vivo microenvironment that is rich in extracellular 
matrix (ECM) and sequestered growth factors (Discher et al., 2009). For stem cell 
differentiation, it is important for in vitro culture conditions to emulate the native 
microenvironment as differentiation to a specific lineage is governed by specific cues 
within each unique local microenvironment (Moore and Lemischka, 2006). The 
extracellular microenvironment has a high solute content of macromolecules which 
occupy volume and exclude like-sized molecules through steric repulsion (Ellis, 
2001). Macromolecules such as proteins, carbohydrates, lipids and nucleic acids 
found in biological systems typically have a size range of 50-500kDa (Chen et al., 
2011). In vitro cell culture systems commonly employ 5-20% foetal bovine serum in 
culture media resulting in a macromolecular solute content of 4-16mg/ml (Chen et al., 
2011), which is much lower than that observed in interstitial fluids (30-40 mg/ml) 
(Bates et al., 1993) or blood plasma (80 mg/ml) (Wadsworth and Oliveiro, 1953). 
Biological reactions performed in dilute in vitro conditions proceed at much slower 
rates than in in vivo conditions which have a much higher macromolecular solute 
content (Minton, 2001), Volume exclusion due to the high macromolecular solute 
content lowers the configurational entropy, leading to an elevated basal free energy of 
reactant macromolecules which results in increased reaction rates (Chen et al., 2011; 
Ellis, 2001). Hence it is no surprise that the sparse microenvironment formation in 
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vitro culture systems fails to replicate the in vivo conditions.  It is based on this 
observation of the lack of “crowdedness” in in vitro cell culture systems that I 
introduce macromolecular crowding (MMC) to address this issue. MMC is defined by 
exerting an excluded-volume effect (EVE) due to the addition of one or more types of 
inert macromolecules of size 50-500kDa with low viscosity in solution into the 
system in order to increase the rate of various extracellular biological reactions, such 
as the deposition and remodeling of the extracellular matrix (Chen et al., 2011). The 
amount of EVE is dependent on the fraction volume occupancy (FVO) of the 
macromolecules. The calculation of the FVO, expressed as the percentage volume 
that the macromolecules occupy at a given concentration x g/ml assumes that the 
soluble macromolecules are mutually impenetrable and form spheres of a certain 
hydrodynamic radius (Chen et al., 2011): 
 
It was previously reported that using MMC in cell culture increased ECM deposition 
in various cell types, enabling them to build their respective microenvironments in 
vitro with greater speed and efficiency (Chen et al., 2011; Chen et al., 2009; Zeiger et 
al., 2012). 
Adult human bone marrow mesenchymal stem cells (bmMSCs) are 
multipotent stem cells of mesodermal origin with the ability to differentiate into bone, 
cartilage and fat (Mackay et al., 2006; Pittenger et al., 1999). Given their relative ease 
of isolation and expansion to sustainable numbers, bmMSCs would be an ideal cell 
source if they could be induced to differentiate to brown adipocytes also of 




where r is the hydrodynamic radius of the molecule in m3 




where M is the molar mass of the molecule in g/mol and NA is the 
Avogadro constant = 6.023 x 1023 molecules/mol 






÷ 𝟏𝟎−𝟔 × 𝟏𝟎𝟎% 
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mesodermal origin. Currently, adult bmMSCs have been shown to differentiate into 
white but not into brown adipocytes (Mackay et al., 2006) using the classic 
adipogenic cocktail (insulin, dexamethasone, indomethacin and 3-isobutyl-
1methylxanthine (IBMX)) as established by (Pittenger et al., 1999). I have recently 
described an improved WAT differentiation model that encompasses adipogenesis 
from adult human bmMSCs to higher degree of maturation using MMC with 
polysucrose polymers (Ficoll). The enhanced adipogenesis was caused by dynamic 
cell-matrix reciprocity between the differentiating bmMSCs and the increased 
deposition and remodelling of the ECM which tunes the microenvironment to 
augment adipogenic differentiation (Ang et al., 2014). As MMC is able to enhance 
white adipogenic differentiation of bmMSCs, I questioned the possibility of MMC 




So far literature has assumed that adult human bmMSCs differentiate into white 
adipocytes based on the absence of UCP1, and in Ang et al. (2014) we further 
assumed that WAT differentiation was augmented when the cells were adipogenically 
induced under MMC using Ficoll. This project is based on stepping back and asking 
the fundamental question: “What kind of adipocytes are we obtaining in our cultures 
when bmMSCs are differentiated under crowded conditions?” I initially hypothesized 
that white adipogenesis would be enhanced in bmMSC-derived adipocytes grown 
under MMC using the classic adipogenic cocktail. However, when I performed qPCR 
on my samples with a home-made UCP1 primer I realized that UCP1 was 
upregulated in adipocytes generated under MMC. It was indeed a serendipitous 
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finding. This led me to speculate that adult human bmMSCs may have the intrinsic 
potential to differentiate into brown adipocytes under the right conditions without 
genetic manipulation, a phenomenon not described before. As adult bone marrow 
mesenchymal stem cells (bmMSCs) are multipotent of mesodermal origin, and are 
able to differentiate into white adipocytes, I hypothesized that bmMSCs possess the 
intrinsic potential to differentiate into brown adipocytes, also of mesodermal origin. 
This potential would be augmented by macromolecular crowding (MMC). The 
specific hypotheses are: 
1. Adult human bmMSCs possess the intrinsic potential to differentiate into 
functional brown adipocytes. 
2. The potential of bmMSCs to differentiate into functional brown adipocytes is 
greatly augmented with the addition of Ficoll during adipogenic induction. 
3. Ficoll augments brown adipogenesis in adult human bmMSCs through the 
generation of macromolecular crowding (MMC) in the cultures which 
enhances the microenvironment formation of the bmMSC-derived adipocytes 
towards a mature adipocyte phenotype. 
 
The proposed work here suggests that adult human bmMSCs could be another 
important and highly interesting source of brown adipocyte progenitors by 
demonstrating that through the use of MMC in our cell culture systems, adult human 
bmMSCs can differentiate into functional brown adipocytes.  
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CHAPTER 2: MATERIALS AND METHODS 
 
2.1 Calculation for emulating bone marrow crowdedness and choice of 
macromolecular crowder 
Calculations for bone marrow crowdedness and choice of crowder were performed as 
described previously (Chen et al., 2011). As no data is available for the calculation of 
bone marrow crowdedness, concentration of albumin with hydrodynamic radius = 
4nm, in blood serum was used to estimate the fractional volume occupancy (FVO) of 
bone marrow (Chen et al., 2011). Referring to the equation in Introduction section 
1.9: 
Concentration of albumin in blood = 80mg/ml 
Hydrodynamic radius of albumin = 4nm 
MW of albumin = 69 000 Da 
Volume of one albumin molecule =
4
3
π𝑟3 = 268.1 × 10−27m3 







× 6.023 × 1023molecules 
𝑭𝑽𝑶 (𝒗/𝒗) = (268.1 × 10−27) × (
0.08
69000
× 6.023 × 1023) ÷ 10−6 × 100%
= 𝟏𝟖. 𝟕% 
The choice of using FicollTM70 and FicollTM400 (PM70 17-0310-50 and PM400 17-
0300-50, GE Healthcare, Bio-sciences AB, Uppsala, Sweden) at the prescribed ratio 
of 37.5mg/ml and 25mg/ml respectively had been determined experimentally by past 
colleagues to be optimal for bmMSC culture (Chen et al., 2011). Ficoll70 was chosen 
as it has been commonly used as a crowder because of its relatively low viscosity in 
solution (Ellis, 2001; Rashid et al., 2014b). A mixture of Ficoll70 and Ficoll400 was 
used as mixed macromolecular crowding proved to be more effective than crowding 
by a single crowding agent (Chen et al., 2011; Du et al., 2006). When the FVO of the 
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Ficoll cocktail was calculated, it amounted to ~17%, close to the FVO of bone 
marrow, thus providing a possible explanation for the effectiveness of the current 
concentration of these macromolecular crowders used in bmMSC culture (Chen et al., 
2011). The FVO calculations for the Ficoll cocktail are shown below as described in 
Chen et al., (2011): 
Table 2.1. Properties of Ficoll 70 and Ficoll 400. 
Crowder Fc70 Fc400 
Concentration (mg/ml) 37.5 25 
Hydrodynamic radius 4 8 
 
Volume of one Fc400 molecule = 2145 × 10−27m3 
Total number of Fc70 molecules in 37.5mg =
0.0375
70000
× 6.023 × 1023molecules 
Total number of Fc400 molecules in 25mg =
0.025
400000
× 6.023 × 1023molecules 
𝑭𝑽𝑶 (𝒗/𝒗) = [(268.1 × 10−27) × (
0.0375
70000




× 6.023 × 1023)] ÷ 10−6 × 100% = 𝟏𝟔. 𝟕% 
 
2.2 Adult human bone marrow mesenchymal stem cell culture 
Adult human bone-marrow derived mesenchymal stem cells (bmMSCs) were 
obtained commercially (Lonza/Cambrex Bioscience, PT-2501, Walkersville, MD, 
USA) at passage 2 and cultured in low glucose Dulbecco's modified Eagle's medium 
(LGDMEM) supplemented with GlutaMAXTM, 10% foetal bovine serum (FBS), 
100units/ml penicillin and 100μg/ml streptomycin (1% P/S) (10567, 10270 and 
15140, Gibco/Life Technologies, Carlsbad, CA, USA). Cells were maintained at 37˚C 
in a humidified atmosphere of 5% CO2, with medium change every 3-4 days. To 
prevent spontaneous differentiation, cells were maintained at subconfluent levels 
prior to being detached using TrypLE™ Express (12604, Gibco/Life Technologies, 
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Carlsbad, CA, USA), passaged at 1:3 – 4 and cultured to generate subsequent 
passages. Directed differentiation was carried out with cells at passage 5 or 7-8. 
 
2.3 Adipogenic induction of bone marrow mesenchymal stem cells 
Unless stated otherwise, bmMSCs were seeded at an initial density of 10.5k cells/cm2 
in well plates. Adipogenic differentiation was stimulated when the cells reached 
confluence as described (McBeath et al., 2004; Pittenger et al., 1999) (with 
modifications) via three or six cycles of 4 days of induction, followed by 3 days of 
maintenance. Non-induced control bmMSCs were maintained with basal medium 
alone on the same schedule. The basal medium used in the differentiation process 
consisted of high glucose Dulbecco’s modified Eagle’s medium (HGDMEM) 
supplemented with GlutaMAXTM, 10% foetal bovine serum (FBS), 100units/ml 
penicillin and 100μg/ml streptomycin (1% P/S) (10569, 10270 and 15140, Gibco/Life 
Technologies, Carlsbad, CA, USA). For white adipocyte differentiation, the induction 
medium was supplemented with 0.5mM 3-isobutyl-1methylxanthine (IBMX), 0.2mM 
indomethacin, 1μM dexamethasone and 10μg/ml insulin (I5879, I7378, D4902 and 
I6634/91077C, Sigma-Aldrich, St-Louis, MO, USA). Basal medium alone was used 
during the maintenance phase. For brown adipocyte differentiation, cells were pre-
treated with 125ng/ml (8.0nM) bone morphogenetic protein 7 (BMP7) (354-BP, R&D 
Systems, Minneapolis, MN, USA) in LGDMEM (with FBS and 1% P/S) 3 days prior 
to induction. The brown adipogenic induction medium was supplemented with 
0.5mM IBMX, 0.2mM indomethacin, 1μM dexamethasone, 10μg/ml insulin, 1nM 
triiodothyronine (T3, T5516, Sigma-Aldrich, St-Louis, MO, USA) and 1μM 
rosiglitazone (ALX-350-125, Enzo Life Sciences Inc., Farmingdale, NY, USA). 
Basal medium alone was used during the maintenance phase. For conditions treated 
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with macromolecular crowding (+MMC), the medium was supplemented with a 
cocktail of macromolecules; FicollTM70 at 37.5mg/ml and FicollTM400 at 25mg/ml 
(PM70 17-0310-50 and PM400 17-0300-50, GE Healthcare, Bio-sciences AB, 
Uppsala, Sweden), throughout the differentiation process. The cocktail of 
macromolecules was dissolved in the medium at room temperature (RT) with gentle 
agitation, and then sterile filtered with a 0.2μm syringe filter (16532, Satorius Stedim 
Biotech GmbH, Goettingen, Germany) prior to use. Figure 2.1 shows the 3-week 
induction timeline. For stimulation with forskolin (F6886 Sigma-Aldrich, St-Louis, 
MO, USA), 10μM was used. Unstimulated cultures were incubated with either only 
basal medium (without MMC) or with the addition of an equal amount of dimethyl 
sulfoxide (DMSO) as a vehicle. 
 
Figure 2.1. 3-week induction timeline of adipogenic differentiation of bmMSCs. 
hbmMSCs were seeded in well plates and adipogenic differentiation was induced at 
confluence. 3 days before induction, cells to be treated with a brown induction protocol were 
treated with BMP7 prior to adipogenic differentiation. Adipogenic differentiation was 
performed on the cells via 3 cycles of a 4-day treatment with induction media followed by a 
3-day treatment with maintenance media. The Ficoll cocktail used to generate 
macromolecular crowding (MMC) were added throughout the adipogenic differentiation 
period for the MMC conditions.  
34 
 
2.4 Culture and adipogenic induction of progenitors isolated from the stromal 
vascular fraction (SVF) of abdominal subcutaneous fat 
The progenitor cells, isolated from the SVF of abdominal subcutaneous adipose 
tissue, were a kind gift from Dr. Sue-Anne Toh at passage 4. The cells were cultured 
in high glucose Dulbecco’s modified Eagle’s medium (HGDMEM) supplemented 
with GlutaMAXTM, 10% foetal bovine serum (FBS), 100units/ml penicillin and 
100μg/ml streptomycin (1% P/S) (10569, 10270 and 15140, Gibco/Life 
Technologies, Carlsbad, CA, USA). Cells were maintained at 37˚C in a humidified 
atmosphere of 5% CO2, with medium change every 3-4 days. To prevent spontaneous 
differentiation, cells were maintained at subconfluent levels prior to being detached 
using TrypLE™ Express (12604, Gibco/Life Technologies, Carlsbad, CA, USA). 
Directed differentiation was carried out with the cells at passage 5. Adipogenic 
differentiation of these cells followed the protocols used for bmMSCs. 
 
2.5 Nile Red area quantification 
Cells were seeded in a 24-well plate format (662160, Cellstar, Greiner, Bio-one 
GmbH, Frickenhausen, Germany). Monolayers were washed in PBS, fixed in 4% 
methanol-free formaldehyde (28908, Pierce Biotechnology Inc., Rockford, IL, USA) 
for 30min at RT, then co-stained for 30min with 5μg/ml Nile Red (N3013, Sigma-
Aldrich, St-Louis, MO, USA), for cytoplasmic lipid droplets and 0.5μg/ml of 4',6-
diamidino-2-phenylindole (DAPI) (D3571, Molecular Probes®, Life Technologies, 
Carlsbad, CA, USA) for nuclear DNA as described previously (Greenspan et al., 
1985). Images were captured with an IX71 inverted fluorescence microscope 
(Olympus, Center Valley, PA, USA). Adherent cytometry was performed according 
to previously described protocol (Ang et al., 2014; Chen et al., 2009). Nine image 
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sites per well were acquired using a 2X objective with a coolSNAP HQ camera 
attached to a Nikon TE2000 microscope (Nikon Instruments, Melville, NY, USA), 
stored and analysed using the Metamorph Imaging System Software 6.3v3 
(Molecular Devices, Sunnyvale, CA, USA). An image field of 4.48 x 3.34mm per site 
was defined for each 24-well plate with a final image of 13.43 x 10.03mm; covering 
134.70 mm2 per well. Nile Red was viewed under a rhodamine filter [Ex 
545nm/Em610nm] while DAPI fluorescence was assessed with a DAPI filter 
[Ex350nm/Em460nm]. The Cell Count module was used for cell enumeration while 
the Integrated Morphometry Analysis module was used to evaluate the area of 
fluorescent Nile Red staining. A specified threshold defined by fluorescent intensity 
below a defined pixel value was subtracted to eliminate background area. In addition, 
triangle masks were applied to remove autofluorescence of corners. Extent of 
adipogenic differentiation was quantified by area of Nile Red fluorescence from 
thresholded events normalized to nuclei count. End data corresponded to total area of 
lipid droplets present per well normalised to cell number μm2/nuclei) and the average 
of biological triplicate was taken. 
 
2.6 Flow cytometry of Nile Red-positive cells 
Cells were seeded in a 6-well plate format (657160, Cellstar, Greiner, Bio-one 
GmbH, Frickenhausen, Germany). Monolayers were washed twice in PBS, 
trypsinised and pelleted by centrifugation for 5min at 200g. ~100k cells per sample 
were fixed with 1% methanol-free formaldehyde (28908, Pierce Biotechnology Inc., 
Rockford, IL, USA) for at least an hour at 4oC, then stained with Nile Red (10μg/ml 
in PBS) for 30min in the dark at RT (adapted from (Abdallah et al., 2004)). Samples 
were washed and resuspended in phophate buffered saline (PBS), filtered using a 
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60µm nylon mesh to remove debris (03-60/42, Lab Pak Sefar Nitex, Sefar AG, 
Heiden, Switzerland) and analysed using a Beckman Coulter CyAnTM ADP Analyzer 
(Beckman Coulter, Inc., Fullerton, CA, USA). Nile Red fluorescence was measured 
on the FL2 emission channel through a 585 ± 21nm band pass filter, following 
excitation with an argon ion laser source at 488nm. Using a forward scatter 
(FSC)/side scatter (SSC) representation of events, a gating region was defined to 
exclude cellular debris from the analysis. Using an overlay histogram (event 
count/FL2) with non-induced MSCs stained with Nile Red as background control, a 
bar region was established on the gated population to count cells with high FL2 
values (adipocytes). Data analysis was performed using Summit 4.3 software 
(Beckman Coulter, Inc., Fullerton, CA, USA). Each sample represented 4-5k gated 
events. Results were expressed as percentage of cells appearing in the bar region. 
Experiment was performed in duplicate. 
 
2.7 Quantitative polymerase chain reaction (qPCR) 
Total RNA was extracted from monolayers in a 12-well plate format (665180, 
Cellstar, Greiner, Bio-one GmbH, Frickenhausen, Germany) using Trizol (15596, 
Gibco/Life Technologies, Carlsbard, CA) and chloroform (C2432, Sigma-Aldrich, St-
Louis, MO, USA) followed by the RNeasy® Mini Kit 250 (74106, Qiagen, Hilden, 
Germany) according to the manufacturer’s protocol. Concentration of isolated RNA 
was determined by measuring the absorbance ratio at 260/280nm using Nanodrop 
(ND-1000, Thermo Fisher Scientific Inc., Waltham, MA, USA). cDNA were 
synthesized from isolated mRNA using the Maxima™ First strand cDNA synthesis 
kit (K1642, Fermentas, Thermo Fisher Scientific Inc., Rockford, IL, USA). Real time 
qPCR was performed and monitored on a real-time PCR instrument (MxPro 3000P 
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QPCR, Stratagene, Agilent Technologies Inc., Santa Clara, CA, USA) using 
Maxima™ SYBR Green/ROX qPCR Master Mix (K0222, Fermentas, Thermo Fisher 
Scientific Inc, Rockford, IL, USA). Data analysis was carried out with the MxPro 
software v4.01 (Stratagene, Agilent Technologies Inc., Santa Clara, CA, USA). For 
each cDNA sample, the Ct value was defined as the cycle number at which the 
fluorescence intensity reached the amplification based-threshold fixed by the 
instrument-software. Relative gene expression levels were determined using the -
Ct method. Unless stated otherwise, the results were normalised to the geometric 
mean of human ribosomal phosphoprotein P0 (RPLP0) and TATA-box binding 
protein (TBP). Primer sequences used are shown in Table 2.2. 
 
Table 2.2. List of primers used in qPCR analysis. 
Gene Accession no. Reference Forward primer Reverse Primer 







































































TMEM26 NM_178505.6 ATGGAGGGACTGGT CTTCACCTCGGTCAC
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Gene Accession no. Reference Forward primer Reverse Primer 
CTTCCTT TCGC 
ZIC1 NM_003412.3 






















































RPLP0 = ribosomal phosphoprotein P0, TBP = TATA-box binding protein, FABP4 = fatty 
acid binding protein 4, GLUT4 = glucose transporter type 4, HSL = hormone sensitive lipase, 
LEP = leptin, UCP1 = uncoupling protein 1, PRDM16 = PRD1-BF1-RIZ1 homologous 
domain containing 16, PGC1α = PPARγ co-activator 1α, DIO2 = deiodinase, iodothyronine, 
type II, ELOVL3 = elongation of very long chain fatty acid elongase 3, TBX1 = T-box 1, 
TMEM26 = transmembrane protein 26, ZIC1 = zinc finger protein of the cerebellum 1, 
HOXC9 = homeobox C9, LHX8 = LIM homeobox protein 8, ITGB1 = integrin beta 1, ITGA1 
= integrin alpha 1, ITGA2 = integrin alpha 2, FGF1 = fibroblast growth factor 1, FGF2 = 
fibroblast growth factor 2, FGF21= fibroblast growth factor 21. 
 
2.8 Western blotting 
Protocol was adapted from (Tan et al., 2013). Cells were seeded in a 6-well plate 
format (657160, Cellstar, Greiner, Bio-one GmbH, Frickenhausen, Germany). Protein 
was extracted as whole cell lysates from cell monolayers with Laemmli buffer 
(31.25mM Tris-HCl pH 6.8, 1% SDS, 0.005% bromophenol blue and 9.5% glycerol) 
and protease inhibitor cocktail (Roche, Basel, Switzerland). Sample protein extracts 
were separated using SDS-PAGE under reducing conditions and then transferred onto 
a nitrocellulose membrane (Bio-Rad, Hercules, CA, USA). For immune-detection, the 
membrane was first blocked with 5% non-fat milk in Tris buffered saline with 
Tween20 (TBST) for 1h at RT, then incubated with the primary antibody in 1% non-
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fat milk in TBST for 1.5h at RT. Primary antibodies used were anti-rabbit UCP1 
(1:100, ab10983 Abcam, Cambridge, UK) and anti-mouse β-actin (1:1000 A228 
Sigma-Aldrich, St-Louis, MO, USA) as a loading control. Bound primary antibody 
was detected with Dako HRP goat-anti mouse antibody (P0447) or Dako HRP goat-
anti rabbit antibody (P0447 and P0448, Dako, Glostrup, Denmark) at 1:1000 in 1% 
non-fat milk in TBST for 1h at RT. Chemiluminescence was captured with a 
VersaDoc Imaging System (5000MP, Bio-Rad, Hercules, CA, USA) and analysed 
with Quantity One Image analysis software (Bio-Rad, Hercules, CA, USA). After 
detecting UCP1, the blot was stripped (stripping buffer – 7.5g glycine, 0.5g SDS, 5ml 
Tween20 in 500ml ddH2O at pH2.2) (formulation was obtained from Abcam 
protocols, Abcam, Cambridge, UK) and blocked before detecting for β-actin. 
 
2.9 Immunocytochemistry of UCP1 
Cells were grown on glass coverslips. Monolayers were fixed with 4% methanol-free 
formaldehyde (28908, Pierce Biotechnology Inc., Rockford, IL, USA). The samples 
were then permeabilised with 0.1% Triton-X for 10min at RT then blocked with 3% 
bovine serum albumin (BSA) (A9647, Sigma-Aldrich, St-Louis, MO, USA) and 0.1% 
Tween20 in PBS for 1h at RT. Immunofluorescence was carried out using primary 
antibody rabbit anti-human UCP1 1:1000 (U6382, Sigma-Aldrich, St-Louis, MO, 
USA), incubation for 16 hours at 4°C in a humidified chamber. Secondary antibody 
used was AlexaFluor® 594 goat anti-rabbit (A11072, Molecular Probes®, Life 
Techonologies, Carlsbad, CA, USA) at 1:400 dilution, incubation of 1 hour at RT. 
Cell nuclei were counterstained with 0.5µg/ml DAPI (D1306, Molecular Probes®, 




2.10 Determination of membrane potential by JC-1 
Cells were seeded in 8-well Nunc labtek chamber slides (155411, Thermo Fisher 
Scientific Inc., Waltham, MA, USA). Cells were washed in PBS and incubated with 
5µM 5,5′,6,6′-tetrachloro-1,1′,3,3′-tetraethylbenzimi-dazolocarbo-cyanine iodide (JC-
1) (T3168, Molecular Probes®, Life Technologies, Carlsbad, CA, USA) for 15min at 
37ºC. Cells were then washed in PBS and stimulated with 10µM forskolin or DMSO 
for 4h before images were taken using confocal microscopy. 
 
2.11 Measuring mitochondrial oxygen consumption 
Cells were seeded at a higher density of 10k/well (33k cells/cm2) in the XF24 cell 
culture plates (100850-001, XK24 Fluxpacks, Seahorse Bioscience, Chicopee, MA, 
USA). Cells were washed once in HBSS and incubated in 500μl of XF assay medium 
(Seahorse Bioscience, Chicopee, MA, USA) for about 20min at 37ºC in the absence 
of CO2 before loading into the Seahorse XF24 analyser (Seahorse Bioscience, 
Chicopee, MA, USA) to measure the oxygen consumption rate (OCR). 10µM 
Forskolin (or DMSO as vehicle control) was added to stimulate the cells for 100min. 
Oligomycin (2μM), carbonyl cyanide-ptrifluoromethoxyphenylhydrazone (FCCP) 
(0.6μM), and Rotenone (2μM) plus Antimycin A (2μM) from the XF Cell Mito Stress 
Test Kit (101706-100, Seahorse Bioscience, Chicopee, MA, USA) were then added 
sequentially to dissect the different components contributing to total oxygen 
consumption in each well: mitochondrial respiration = OCR just before the addition 
of oligomycin; uncoupled respiration = the minimum OCR after the addition of 
oligomycin before FCCP; respiratory capacity = the highest OCR after the addition of 
FCCP. The minimum OCR after the addition of rotenone and antimycin A were 
subtracted from these values to account for non-mitochondrial respiration. After 
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measurement, cells were lysed using 0.1mg/ml Proteinase K (P2308, Sigma-Aldrich, 
St-Louis, MO, USA) (enzyme was dissolved in 10mM Tris-HCl pH 8.5-9.0 with 40% 
glycerol to a concentration of 1mg/ml, then diluted to a working concentration of 
0.1mg/ml in lysis buffer consisting of 10mM Tris-HCl (pH 8.5), 1mM EDTA, 0.1% 
(v/v) Triton X-100) and dsDNA content was measured using Quant-iT™ PicoGreen® 
dsDNA Kit (MP7581, Molecular Probes®, Life Techonologies, Carlsbad, CA, USA). 
Raw OCR data were normalized by the amount dsDNA in each well before analysis. 
 
2.12 Immunocytochemistry of extracellular matrix deposition 
Images were captured with an IX71 inverted fluorescence microscope (Olympus, 
Center Valley, PA, USA). Adherent cytometry was performed according to 
previously described protocol (Ang et al., 2014; Chen et al., 2009). Nine image sites 
per well were acquired using a 2X objective with a coolSNAP HQ camera attached to 
a Nikon TE2000 microscope (Nikon Instruments, Melville, NY, USA), stored and 
analysed using the Metamorph Imaging System Software 6.3v3 (Molecular Devices, 
Sunnyvale, CA, USA). An image field of 4.48 x 3.34mm per site was defined for 
each 24-well plate with a final image of 13.43 x 10.03mm; covering 134.70 mm2 per 
well. Fluorescent ECM proteins were viewed under a fluorescein isothiocyanate (FITC) 
filter [Ex470nm/Em525nm] and a Texas Red filter [Ex572nm/Em630nm] while 
DAPI fluorescence was assessed with a DAPI filter [Ex350nm/Em460nm]. The Cell 
Count module was used for cell enumeration while the Integrated Morphometry 
Analysis module was used to evaluate the area of fluorescent staining. A specified 
threshold defined by fluorescent intensity below a defined pixel value is subtracted to 
eliminate background area. In addition, triangle masks were applied to remove 
autofluorescence of corners. Extent of ECM deposition was quantified by area of 
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fluorescence from thresholded events normalized to nuclei count. End data 
corresponded to total area of ECM deposition present per well normalised to cell 
number μm2/nuclei). The end data per well was substracted off its corresponding 
secondary antibody conjugate control before the average of biological triplicate is 
taken. 
 For confocal microscopy studies, Cells were seeded in 35mm dishes with 
glass bottom coverslips (3911-035, Iwaki, Scitech Division, Asahi Techno Glass, 
Tokyo, Japan). Monolayers were fixed with 4% methanol-free formaldehyde (28908, 
Pierce Biotechnology Inc., Rockford, IL, USA) for 10min at RT, then blocked with 
3% bovine serum albumin (BSA) (A9647, Sigma-Aldrich, St-Louis, MO, USA) in 
PBS for an hour. Immunofluorescence was carried out using primary antibodies 
rabbit anti-human collagen IV 1:500 (6586 Abcam, Cambridge, UK), incubation for 
16 hours at 4°C. Secondary antibody used is AlexaFluor® 594 goat anti-rabbit 
(A11072, Molecular Probes®, Life Techonologies, Carlsbad, CA, USA) at 1:400 
dilution, incubation of 1 hour at RT. Cell nuclei and neutral lipids were 
counterstained with 0.5µg/ml DAPI (D1306, Molecular Probes®, Life 
Techonologies, Carlsbad, CA, USA) and 0.1µg/ml BOPIDY® (4,4-difluoro-
1,3,5,7,8-pentamethyl-4-bora-3a,4a-diaza-s-indacene, D3922, Molecular Probes®, 
Life Techonologies, Carlsbad, CA, USA). Image acquisition was performed by using 
a Confocal Laser Scanning Microscope (LSM510, Zeiss, Germany) with an EC Plan-
Neofluar 40x/1.30 Oil objective. Images of the collagen IV staining were processed 
using the Image J software (National Institutes of Health, Bethesda, MD, USA) to 
remove background noise and calculate the average pixel intensity per confocal plane, 
which was then plotted against the Z-distance (µm) for each image stack. Assuming a 
normal distribution, the parabolic section of the resulting curve was then fitted to a 
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Gaussian function (Equation 1) using, as floating parameters: the area under the curve 
(A), the peak position (μ) and the standard deviation (σ) (Fig. 2.2). Following the 
density of probability model, the limit of the collagen IV signal along the Z-axis was 
determined as (μ+3σ), with a 99% confidence level, and the corresponding Z-distance 
was used to estimate the thickness of collagen IV. The area under the curve up to the 
limit was obtained using OriginPro 9.1 (OriginLab Corporation, Northhampton, MA, 








  (eq.1) 
 
Figure 2.2. An example of collagen IV matrix characterization using a normal 
distribution. The mean pixel intensity per confocal plane was measured using the Image J 
software and plotted against the vertical Z-distance. A Gaussian curve was fitted to the 
parabolic section of the experimental data, yielding the peak position and the standard 
deviation. The limit of the signal was determined at (μ+3σ), with a 99% confidence level. 




2.13 Elution of FGFs from the extracellular matrix 
Cells were seeded in a 24-well plate format (662160, Cellstar, Greiner, Bio-one 
GmbH, Frickenhausen, Germany). Cell layers were washed with PBS and low 
binding affinity fibroblast growth factors (FGFs) were eluted with 2M NaCl (in 
20mM HEPES, pH 7.4) as previously described for eluting low binding affinity FGF2 
bound to HSPG (Moscatelli, 1992). ELISA was performed on the eluates for the 
detection of fibroblast growth factor 1 (FGF1) and fibroblast growth factor 2 (FGF2) 
(DFA00B and DBF50, R&D Systems, Minneapolis, MN, USA). 
 
2.14 Ficoll uptake studies 
Cells were seeded in 8-well Nunc labtek chamber slides (155411, Thermo Fisher 
Scientific Inc., Waltham, MA, USA) at a higher density of 15k/well (19k cells/cm2). 
Cells were washed in Hank's balanced salt solution (HBSS) and incubated in 
HGDMEM (10% FBS and 1% P/S) without MMC overnight. Cells were then washed 
in HBSS and incubated with 1µM of Ficoll70 or Ficoll400-labelled 
tetramethylrhodamine isothiocyanate (TRITC) (TF70 and TF400, TdB Consultancy, 
Uppsala, Sweden) or just TRITC (87918, Sigma-Aldrich, St-Louis, MO, USA) for 1 
hour at 37ºC. Cells were washed in HBSS and incubated with 200nM Mitotracker 
Green (M7514, Molecular Probes®, Life Techonologies, Carlsbad, CA, USA) for 
15min at 37ºC. Cells were then washed in HBSS, and underwent confocal imaging 




2.15 Statistical analysis  
Unless otherwise stated, all assays were performed in triplicate and results reported as 
mean ± standard error. Student’s t-test was used for comparison between two groups. 
For multiple pairwise comparisons, one-way ANOVA statistical analysis was 
performed followed by Tukey-Kramer Multiple Comparisons Test using Graphpad 
InStat software (GraphPad Software, Inc., La Jolla, CA, USA). n.s. not significant, 
*p<0.05, **p<0.01, ***p<0.001.  
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CHAPTER 3: RESULTS 
 
3.1 Macromolecular crowding using Ficoll enhances adipogenic differentiation 
towards a brown adipocyte phenotype in adult human bone marrow mesenchymal 
stem cells 
Adult human bone marrow mesenchymal stem cells (bmMSCs) were 
subjected to a 3-week adipogenic induction using a white (iw) or a brown (ib) 
induction protocol (refer to Materials and methods section 2.3), and Ficoll, a sucrose 
co-polymer, was used to generate the condition of macromolecular crowding (MMC) 
throughout the differentiation process as described recently (Ang et al., 2014). The iw 
protocol consisted of 3-isobutyl-1methylxanthine (IBMX), indomethacin, 
dexamethasone and insulin as described (Mackay et al., 2006; Pittenger et al., 1999). 
The ib protocol included the addition of factors known to promote brown adipocyte 
differentiation, namely T3 (Klaus et al., 1995), Rosiglitazone (Vernochet et al., 2009) 
and BMP7 (Tseng et al., 2008). To analyse MMC effects on brown adipogenic 
differentiation, mRNA expression of UCP1 and other brown-selective genes 
PRDM16 and CIDEA (refer to Introduction section, table 1.1) were quantified in 
bmMSC-derived adipocytes at the end of the 3-week induction. The ib protocol alone 
failed to significantly upregulate UCP1 expression (Fig. 3.1, ib no mmc group). In 
contrast, under MMC (ib mmc) UCP1 expression was significantly upregulated by 
over 20-fold compared to the iw protocol, and 5-fold compared to ib protocol alone. 
As expected, no UCP1 mRNA upregulation occurred in the iw protocol (compared to 
non-induced controls, data not shown), but surprisingly, UCP1 was upregulated 10-
fold using the iw protocol under MMC (iw mmc) (Fig. 3.1). Interestingly, despite the 
upregulation of UCP1, the expression levels of PRDM16 were not significantly 
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different between groups (Fig. 3.1). CIDEA expression was low (raw Ct values > 32.7 
out of 35 cycles, data not shown) for all groups and hence was considered absent 
from the cultures. 
 
 
Figure 3.1. Macromolecular crowding using Ficoll enhances adipogenic 
differentiation towards a brown-like phenotype in adult human bone marrow 
mesenchymal stem cells. bmMSCs were chemically induced with a white (iw) or brown 
(ib) protocol ± MMC for 3 weeks and qPCR was carried out to assess brown adipogenesis. 
Raw Ct values of the respective genes are reported below the graphs. BAT selective genes: 
UCP1 = uncoupling protein 1, PRDM16 = PRD1-BF1-RIZ1 homologous domain containing 
16, Data are mean ± SEM. n.s. = not significant; *p<0.05; **p<0.01; ***p<0.001. 
 
On the basis of this observation, I set out to optimize a MMC-enhanced brown 
differentiation protocol for bmMSCs using the three key factors BMP7, T3 and 
rosiglitazone in various combinations with the existing white (iw) protocol ±MMC 
(Fig. 3.2). BMP-7 pre-treatment followed by a 3-week induction with T3 and 
rosiglitazone in a standard iw protocol (dexamethasone, IBMX, insulin and 
indomethacin) with MMC was most effective in upregulating UCP1 mRNA 
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expression, and thus was selected as the brown protocol (ib) for the rest of the study 
(Fig. 3.2B).  
 
Figure 3.2. Comparison of various brown induction (ib) protocols. bmMSCs were 
chemically induced with various combinations of browning factors in addition to the base 
white (iw) protocol in the presence or absence of MMC and UCP1 expression was measured 
using qPCR to assess the efficiency of brown adipocyte differentiation. (A) UCP1 expression 
of various conditions compared to the standard white (iw) protocol: iw + T3 = T3 was added 
during the induction, iw + (T3 & BMP7) = cells were pre-treated with BMP7 3 days before 
induction and T3 was added during the induction, iw + (T3 and Rosi) = T3 and rosiglitazone 
were added during the induction. (B) UCP1 expression of various conditions compared to the 
standard white (iw) protocol: iw + (T3 and Rosi) = T3 and rosiglitazone were added during 
the induction, iw + (T3, Rosi and BMP7) (the current ib protocol) = cells were pre-treated 
with BMP7 3 days before induction and T3 + rosiglitazone were added during the induction. 





I next characterized the bmMSC-derived adipocytes generated under the 
various conditions. The differentiated adipocytes assumed a rounded morphology, 
compared to undifferentiated controls which were spindle-shaped (Fig. 3.3A). It was 
observed that the cultures with MMC appeared to have a slightly higher cell density 
than the non-MMC cultures (Fig. 3.3B). bmMSC-derived adipocytes accumulated 
massive amounts of lipid droplets (Fig. 3.4A-B) which were morphologically 
multilocular, forming grape-like structures (Fig. 3.4C). 
 
Figure 3.3. bmMSC-derived adipocytes after a 3-week induction with a white 
(iw) or brown (ib) induction protocol ± macromolecular crowding (MMC). (A) 
Phase contrast images taken at 4X magnification showed the change in cell morphology from 
spindle-like to round and the accumulation of lipid droplets. Scale bar: 500µm. (B) Adherent 
cytometry of DAPI-stained nuclei count to obtain cell numbers in the various conditions. 




Figure 3.4. Increased lipid droplet accumulation under MMC in bmMSC-
derived adipocytes induced with white (iw) or brown (ib) induction protocols. (A) 
Fluorescence images of Nile Red-stained lipid droplets (yellow) and DAPI-stained nuclei 
(blue) at 10X magnification. Scale bar: 200µm. (B) Adherent cytometry of fluorescent Nile 
Red area normalized to cell number (C) Fluorescence images at 40X magnification. Scale 
bar: 200µm. Data are mean ± SEM. n.s. = not significant; *p<0.05; **p<0.01; ***p<0.001.  
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MMC alone did not induce adipogenic differentiation, but yielded in both 
induction protocols a significantly greater lipid droplet accumulation per cell (Fig. 
3.4B). Apparently the proportion of cells differentiating into adipocytes were lower in 
the MMC conditions, i.e. 11.3% decrease in the iw mmc group compared to iw group, 
and a significant 18.9% decrease in the ib mmc group compared to the ib group (Fig. 
3.5). This could be attributed to the higher fragility of the cell membrane of the 
MMC-generated adipocytes due to the increased lipid load which rupture more easily 
by the shear force during the acquisition using flow cytometry, resulting in an 





Figure 3.5. Accelerated adipogenesis under MMC does not increase the 
percentage of differentiating cells. (A) Representative flow cytometry graphs of Nile 
Red positive bmMSC-derived adipocytes induced with iw or ib protocol ±MMC as detected 
by the FL2 channel. (B) Flow cytometric count of Nile Red positive cells over total gated cell 






In addition, the bmMSC-derived adipocytes significantly upregulated the gene 
expression of key markers essential for adipocyte function such as glucose transporter 
type 4 (GLUT4), fatty acid binding protein 4 (FABP4), hormone sensitive lipase 
(HSL) and leptin (LEP) (Fig. 3.6). GLUT4 is an insulin-dependent glucose 
transporter, and facilitates glucose uptake into adipocytes in response to insulin 
stimulation (Funaki et al., 2004). FABP4 is involved in fatty acid trafficking within 
the adipocyte (Hertzel and Bernlohr, 2000), HSL catalyses the hydrolysis of tri- and 
di- acylglycerols during the lipolysis (Lampidonis et al., 2011), and leptin is an 
adipokine that regulates satiety (Klok et al., 2007).  
 
Figure 3.6. Upregulation of key adipocyte genes in bmMSCs induced with the 
white (iw) or brown (ib) protocol ± MMC. Expression of pan-adipocyte genes 
determined by qPCR, compared to non-induced controls (c no mmc group). GLUT4 = 
glucose transporter type 4; FABP4 = fatty acid binding protein 4; HSL = hormone sensitive 




Based on the differential UCP1 expression reported in figure 3.1, I 
investigated whether the UCP1-positive treatment groups correlated with the 
upregulation of classical brown (ZIC1, LHX8) or beige (TBX1, CD137 and TMEM26) 
markers, and the down-regulation of a white (HOXC9) marker compared to iw-
derived adipocytes and non-induced bmMSCs (refer to Introduction section 1.6). 
Classical brown marker ZIC1 had the highest expression in the non-induced 
conditions (c no mmc, c with mmc). There was no difference in expression between 
the induced conditions (Fig. 3.7B). mRNA for LHX8 (LIM homeobox protein 8) was 
not detected in the cultures after 35 cycles (Table 3.1). Beige markers TBX1 and 
TMEM26 were strongly downregulated in the bmMSC-derived adipocytes and there 
was no difference in expression between the induced conditions, while CD137 was 
downregulated in the MMC conditions (Fig. 3.7A). Moreover, the expression levels 
of the beige markers were low (Table 3.1), indicating that these markers may not be 
biologically relevant in bmMSC-derived adipocytes. Lastly, there was no difference 




Figure 3.7. Assessment of lineage markers expression for classical brown, beige 
and white adipocytes. bmMSCs were chemically induced with a white (iw) or brown (ib) 
protocol ±MMC for 3 weeks and qPCR was carried out to assess lineage markers for the 
different populations of brown and white adipocytes in comparison with non-induced 
bmMSCs (c no mmc). (A) Beige selective genes: TBX1 = T-box 1, CD137 = tumor necrosis 
factor receptor superfamily, member 9 (TNFRSF9), TMEM26 = transmembrane protein 26. 
(B) Classical-brown selective gene: ZIC1 = Zic family member 1. (C) White selective gene: 
HOXC9 = homeobox C9. Data are mean ± SEM. n.s. = not significant; *p<0.05; **p<0.01; 
***p<0.001. 
 
Table 3.1. Raw Ct values of classical brown, beige and white markers. 
Type Marker c c mmc iw iw mmc ib ib mmc 
Classical 
brown 
ZIC1 26.1 ± 0.1 26.3 ± 0.1 26.7 ± 0.1 26.9 ± 0.1 26.9 ± 0.1 27.0 ± 0.0 
LHX8 no Ct no Ct no Ct no Ct no Ct no Ct 
Beige TBX1 30.4 ± 0.1 30.6 ± 0.1 32.3 ± 0.3 32.4 ± 0.1 32.8 ± 0.3 32.3 ± 0.1 
CD137 30.6 ± 0.2 32.2 ± 0.2 31.3 ± 0.0 32.2 ± 0.1 31.1 ± 0.2 32.0 ± 0.0 
TMEM26 30.4 ± 0.1 30.1 ± 0.2 32.9 ± 0.1 32.7 ± 0.3 33.1 ± 0.0 32.9 ± 0.1 
White HOXC9 24.9 ± 0.1 24.5 ± 0.1 25.3 ± 0.0 25.1 ± 0.1 25.3 ± 0.1 25.0 ± 0.0 




3.2 MMC-generated brown adipocytes derived from adult human bone marrow 
MSCs are functional 
An important test for functional brown adipocytes is their thermogenic response to an 
adrenergic stimulus or the more generic downstream induction of cAMP by forskolin 
(refer to Introduction section, figure 1.2). I first investigated whether the bmMSC-
derived adipocytes responded to a forskolin-dependent increase in cAMP by 
measuring their lipolytic response as both white and brown adipocytes undergo 
lipolysis upon a β-adrenergic stimulus (Robidoux et al., 2004; Souza et al., 2007). 
After a 16h forskolin stimulus, both iw- and ib- generated adipocytes ±MMC 
responded to this stimulus by emptying their lipid stores by 50-60% (Fig. 3.8A). 
Fluorescence images of the Nile Red-stained adipocytes showed that the forskolin-
treated cells (Fig. 3.8D-E) had a significant decrease in intracellular lipid stores 





Figure 3.8. bmMSC-derived adipocytes undergo lipolysis upon forskolin 
stimulation. Adipocytes that were differentiated from bmMSCs were subjected to a 
forskolin (10µM) stimulus, and lipolysis was assessed by quantifying the loss of lipid stores. 
(A) Extent of lipolysis after a 16h forskolin treatment as captured by adherent cytometry 
quantifying Nile Red-positive area normalized to nuclei count. (B and C) vehicle treatment 
only, (D and E) 16h forskolin of ib mmc adipocytes. c = non-induced control; iw = white 
cocktail; ib = brown cocktail. Scale bar for 20X: 200µm. Scale bar for 40X: 100µm.  
 
Next, to specifically assess the thermogenic response to a forskolin stimulus, I 
treated the cells with forskolin and measured the expression of thermogenic genes 
compared to vehicle controls. After a 4.5h forskolin stimulus, all MMC-generated 
adipocytes showed a greater upregulation of thermogenic genes PGC1α and DIO2 
compared to induction with cocktail alone. In addition, UCP1 upregulation was 
significant only in the bmMSC-derived adipocytes induced with MMC (430-fold for 




Figure 3.9. Brown adipocytes generated under MMC significantly upregulate 
thermogenic genes upon forskolin stimlulation. Adipocytes that were differentiated 
from bmMSCs were subjected to a forskolin (10µM) stimulus, and qPCR was performed to 
determine mRNA expression of thermogenic genes after a 4.5h forskolin treatment. UCP1 = 
uncoupling protein 1; PGC1α = PPARγ co-activator 1α; DIO2 = deiodinase, iodothyronine, 
type II. Data are mean ± SEM. ns. = not significant; *p<0.05; **p<0.01; ***p<0.001. 
 
To further investigate the effect of UCP1 activation in mitochondrial 
membrane depolarisation due to the dissipation of the proton gradient (refer to 
Introduction section, figure 1.1), I made use of a cyanine cationic dye JC-1 (5,5′,6,6′-
tetrachloro-1,1′,3,3′-tetraethylbenzimidazolocarbo-cyanine iodide). When 
accumulated preferentially in the interior-negative potential environment of the 
mitochondrial matrix the dye forms J-aggregates with emission at 585nm (orange-
red) at high concentrations. When the mitochondrial membrane potential (Δψm) 
decreases, there is an increased dissociation of J-aggregates to the monomer form 
with emission at 520nm (green) (Mathur et al., 2000; Smiley et al., 1991). Thus the 
spectral shift from orange-red to green indicates mitochondrial membrane 
depolarisation, which can be caused by uncoupled respiration due to the increased 
activity of UCP1. After a 4h forskolin stimulus, mitochondrial membrane 
depolarisation was observed to a greater extent in MMC-generated adipocytes when 
compared to vehicle controls (Fig. 3.10), which predicted an increased uncoupling 
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Figure 3.10. Brown adipocytes generated under MMC show increased 
mitochondrial membrane depolarization after a forskolin stimulus. Adipocytes 
differentiated from bmMSCs were subjected to a forskolin (10µM) stimulus, and 
mitochondrial membrane depolarization was assessed. (G) JC-1 staining of MSC-derived 
adipocytes after a 4h forskolin treatment (f) compared to vehicle (v) controls. Depolarised 
mitochondrial membranes appear in green. Scale bar: 200µm. 
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Finally, as a functional marker confirming a thermogenic response, the 
oxygen consumption rate (OCR) was determined in real time using the Seahorse XF 
analyser following a forskolin stimulus, and the mitochondrial function 
(mitochondrial respiration, uncoupled respiration and respiratory capacity) after 
forskolin stimulation was determined with the addition of the various metabolic 
compounds oligomycin, FCCP, rotenone and antimycin A in the sequence shown 
(Fig. 3.11A) (refer to Materials and Methods section 2.7). Brown-induced ib mmc 
adipocytes from an early passage showed an enhanced oxygen consumption rate 
(OCR) and uncoupled respiration over and above white (iw) adipocytes. In a 100min 
time window OCR increased in ib mmc by 40% compared to a 17% decrease in white 
adipocytes (iw) (Fig. 3.11B). Brown (ib mmc) adipocytes also showed a significant 
80% increase in mitochondrial (Fig. 3.11C) and a 260% increase in uncoupled 
respiration (Fig. 3.11D), while white (iw) adipocytes did not respond significantly to 
the forskolin stimulus. The overall respiratory capacity of ib mmc adipocytes, 






Figure 3.11. bmMSC-derived brown adipocytes generated under MMC show an 
enhanced forskolin response compared to white induced (iw) adipocytes. Cell 
cultures were monitored real-time for respiratory changes in the Seahorse FX analyser and 
afterwards analysed for DNA content. (A) Averaged oxidative respiratory capacity (OCR) of 
each group was normalised to DNA content with the various compounds added during the 
time course of the experiment to assess the mitochondrial respiratory function. (B) OCR ratio 
of forskolin-stimulated ib mmc and iw adipocytes normalized to vehicle controls. (C) 
mitochondrial respiration, (D) uncoupled respiration and (E) respiratory capacity of iw and ib 
mmc adipocytes. Data are mean ± SEM. ns. = not significant; *p<0.05; **p<0.01; 




3.3 MMC-enhanced ECM provides signaling cues to enhance brown adipocyte 
differentiation 
To elucidate the mechanism of the sucrose co-polymer Ficoll in inducing the brown 
phenotype in bmMSC-derived adipocytes, my colleagues and I looked at the MMC 
effects of Ficoll in influencing adipocyte microenvironment formation by 
investigating collagen IV, a major adipocyte extracellular matrix (ECM) component 
(Lilla et al., 2002), and heparin sulphate proteoglycans (HSPG), which play an 
important role in growth factor sequestration (Taipale and Keski-Oja, 1997). 
bmMSC-derived adipocytes generated under MMC produced an enriched ECM 
characterised by a substantially increased deposition of collagen IV (3.4-fold for iw 
mmc and 4.7-fold for ib mmc, respectively) and perlecan, a heparan sulphate 
proteoglycan (2.5-fold and 3.0-fold, respectively) (Fig. 3.12B), consistent with what 
was reported previously (Ang et al., 2014). An in-depth analysis of the Col IV 
deposition using confocal microscopy revealed that the arrangement of Col IV in the 
MMC conditions had finer fibres which enveloped the adipocytes, whereas the non-
MMC conditions had Col IV arranged in thick bundles and generally do not envelope 
the adipocytes (Fig. 3.13A). It is interesting to note that the (ib) induction protocol 
alone also promoted the fine fibre formation in some of the samples (Supp. Fig. 1). 
When the Z-stack images were assessed quantitatively, there was no significant 
difference in the thickness of Col IV deposited between MMC and non-MMC 
conditions, (Fig. 3.13B) although adipocytes induced with the ib protocol seemed to 
have a slightly thicker Col IV matrix. However, the density of Col IV was 
significantly higher in the MMC conditions with a 3.5-fold and 2.1-fold increase for 





Figure 3.12. MMC enhances microenvironment formation during adipogenic 
differentiation. bmMSCs were chemically induced with a white (iw) or brown (ib) cocktail 
± MMC for 3 weeks and ECM deposition was assessed immunocytochemically. (A) 
Immunocytochemistry images of deposited collagen IV (Col IV) and heparan sulphate 
proteoglycan II (perlecan/HSPG). Scale bar: 500µm. (B) Quantitative bioimaging analysis of 
fluorescent area normalized to cell number. Data are mean ± SEM. *p<0.05; ***p<0.001. 







Figure 3.13. MMC increases the density but not the thickness of Col IV during 
adipogenic differentiation. bmMSCs were chemically induced with a white (iw) or brown 
(ib) induction protocol ± MMC for 3 weeks and Z-stack images was obtained for each 
condition through confocal microscopy. (A) Z-project images of DAPI (blue), Col IV (red) 
and BODIPY (green). The inserts are taken from the cross-section views of the Z-stack 
marked by the horizontal solid yellow line in each image. Scale bar: 20µm. (B & C) Bio-
imaging analysis was performed on 3 Z-stacks per condition to assess the thickness (B) and 
the density (C) of Col IV deposited. Data are mean ± SEM. n.s. not significant; *p<0.05; 
**p<0.01; ***p<0.001. Experiment performed together with Anna Goralczyk, Rókus Kriszt, 
Jean-Yves Dewavrin, NUS; and Dr. Cedric Badowski, IMB A*STAR.   
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HSPG is known to sequester FGFs (Turner and Grose, 2010), so I assessed 
whether the enhanced brown adipogenesis in MMC-induced cultures was due to the 
increased sequestration of fibroblast growth factors (FGFs). As there was evidence 
for an autocrine production of both FGF1 and FGF2 at mRNA level (Fig. 3.14A), I 
proceeded to quantify these FGFs sequestered to the ECM. Whole cell layers of ib 
mmc (after three weeks) were treated with 2M NaCl at pH 7.4 to elute low binding 
affinity FGF2 that sequester to HSPG in the ECM as previously described 
(Moscatelli, 1992). This salt wash technique was applied to elute FGF1 as well. Both 
growth factors were recovered from matrices in substantial amounts (60-160 pg/ml), 
with no significant differences between iw and ib but with a tendency to a reduction 
of FGF content across all crowded cultures induced with MMC (Fig. 3.14B). mRNA 






Figure 3.14. MMC-enhanced ECM does not contain more FGFs. bmMSCs were 
chemically induced with a white (iw) or brown (ib) cocktail ±MMC for 3 weeks. qPCR was 
carried out (on a separate experimental set) to determine the expression of FGF1 and FGF2. 
To assess the amount of sequestered FGFs in the matrix, whole cell layers were treated with 
2M NaCl to elute HSPG bound ligands and eluates were analysed by ELISA for presence of 
FGF 1 and 2. (A) Gene expression of FGF1 and FGF2. (B) Salt eluates analysed for presence 
of FGF 1 and 2 by ELISA after completed 3 week adipogenic differentiation. Data are mean 
± SEM. n.s. = not significant. 
 
I reported in (Ang et al., 2014) that MMC-induced adipocytes produce an 
ECM that more closely mimics a native adipocyte matrix in terms of composition and 
structure, which could mediate pro-adipogenic signals to differentiating cells. With 
the increased deposition of col IV I next assessed the expression of integrins that are 
known to bind to collagens, namely α1β1 and α2β1 (Gullberg and Lundgren-
Akerlund, 2002). While the expression levels of ITGA1 and ITGB1 did not differ 
significantly between conditions, the expression of ITGA2 (the gene encoding 
integrin α2) was significantly lower by 30-40% in MMC-generated adipocytes (Fig. 
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3.15), indicative of a more adipogenic phenotype, in accordance with published 
literature (Ullah et al., 2013). 
 
Figure 3.15. MMC modulates ITGA2 expression during adipogenic 
differentiation. bmMSCs were chemically induced with a white (iw) or brown (ib) cocktail 
±MMC for 3 weeks and expression of collagen-binding integrins by qPCR was assessed. 
ITGA1 = integrin alpha 1, ITGA2 = integrin alpha 2, ITGB1 = integrin beta 1. Data are mean 
± SEM. ns. = not significant; **p<0.01. 
 
3.4 “Browning” of bmMSC-derived white adipocytes with MMC 
In the preceding sections, I have shown that sucrose co-polymer Ficoll when used as 
macromolecular crowder could enhance brown adipogenic differentiation of 
bmMSCs. In this section, I probed the system further and questioned whether the 
addition of MMC together with factors which promote brown adipocyte 
differentiation could enhance “browning” on already committed white adipocytes. 
The recruitment of beige adipocytes in a white adipose depot is known as “browning” 
(Bartelt and Heeren, 2014), and this term will be used in this section to describe the 
appearance of UCP1-positive adipocytes in the bmMSC-derived adipocyte cultures 
that previously had no UCP1 mRNA expression. To achieve this aim, bmMSCs were 
first subjected to a standard white (iw) protocol for 3 weeks to generate mature 
bmMSC-derived white adipocytes. Then, for the next three weeks, these bmMSC-
derived white adipocytes were exposed to a white (iw) or brown (ib) induction 
cocktail in the absence or presence of MMC (Fig. 3.16, (W and W/B) no MMC and 
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(W and W/B) MMC after 3 weeks). Other conditions comprising various 
combinations of iw and ib cocktails and the absence or presence of MMC were also 
carried out as controls to assess the browning effect of the cocktail alone and the 
browning effect of MMC alone, generating a total of 8 conditions. At the end of 6 
weeks, qPCR analysis was carried out (Fig. 3.16). 
 
Figure 3.16. 6-week adipogenic induction protocol to assess browning of WAT-
differentiated bmMSCs ±MMC. bmMSCs were subjected for 6 weeks to either a white 
or brown protocol in the presence or absence of MMC. A third group of cultures was subject 
to a white or brown protocol for 3 weeks and then switched to MMC or a brown protocol 





Figure 3.17. bmMSCs differentiated under a 6-week adipogenic induction 
protocol accumulate larger lipid droplets than in a 3-week induction protocol. 
bmMSCs were subjected for 6 weeks to either a white or brown protocol in the presence or 
absence of MMC. A third group of cultures was subject to a white or brown protocol for 3 
weeks and then switched to MMC or a brown protocol with MMC. Phase contrast images at 
4X magnification show accumulation of large lipid droplets (red arrows) in bmMSC-
differentiated adipocytes under a 6-week induction protocol. Scale bar: 500µm. 
 
Morphologically, the bmMSC-derived adipocytes cultured for 6 weeks 
accumulated large lipid droplets (Fig. 3.17, red arrows), which were absent in 
adipocytes at 3 weeks (refer to Fig. 3.3). In the initial experiments, after 
differentiating the bmMSCs using the iw protocol, I treated the cultures with 
browning factors (T3 and rosiglitazone) ± MMC from week 4-6 to investigate their 
potential to induce browning in the 3-week generated bmMSC-derived iw-adipocytes. 
However when the iw cocktail, comprising of dexamethasone, indomethacin, insulin 
and IBMX, was removed from week 4-6, the cultures showed a reversion of cell 
shape from rounded to spindle-like, accompanied by a loss of lipid droplets (Fig. 
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3.18, right panel). Thus I kept the 4 basic differentiation factors of the iw cocktail 
throughout the 6 weeks of differentiation. 
 
Figure 3.18. The standard iw cocktail is needed to maintain the round 
morphology and the accumulation of lipid droplets in bmMSC-derived 
adipocytes. Phase contrast images at 4X magnification of adipocyte cultures at the end of 6 
weeks showing the reversion of cell shape from round to spindle-like and the loss of lipid 
droplets when the iw cocktail (dexamethasone, indomethacin, insulin and IBMX) was 
removed during week 4-6 of culture. Cells were seeded in 12 well plates at 25k/well 
(6.4k/cm2) and grown to confluence before induction. Scale bar: 500µm. 
 
The cultures differentiated according to the designed protocol in figure 3.16 
were then harvested for RNA and qPCR analysis was carried out. bmMSC-derived 
adipocytes differentiated in either iw protocol and the ib mmc protocol for 6 weeks 
served as reference for baseline (1-fold) and maximal UCP1 induction (16-fold), 
respectively (Fig. 3.19). In the absence of MMC, neither the switch to an ib induction 
cocktail after 3 weeks nor a full 6 weeks ib protocol induction led to a significant 
UCP1 expression (1.2-fold, and 1.9-fold, respectively) (Fig 3.19, left column group). 
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In contrast, the addition of MMC to respective induction protocols in week 4-6 
increased UCP1 expression 4.8-fold in iw mmc, 6.1-fold (ib mmc) and 8.6-fold when 
the iw induction cocktail was switched to the ib induction cocktail (Fig. 3.19, middle 
column group). Of note, 6 weeks of iw mmc induced cultures achieved 14-fold 
UCP1, closely approaching maximal UCP1 induction values (16-fold) obtained for 6 
weeks of ib mmc induction (Fig. 3.19, right column group). In contrast, pan-
adipocyte genes FABP4 and LEP did not show a significant upregulation from the iw-
generated adipocytes as a baseline (Fig. 3.20), indicating that the upregulation of 
UCP1 was unique.  
 
Figure 3.19. Browning of WAT-differentiated bmMSCs with MMC. bmMSCs 
were subjected for 6 weeks to either a white or brown protocol in the presence or absence of 
MMC. A third group of cultures was subjected to a white or brown protocol for 3 weeks and 
then switched to MMC or a brown protocol with MMC. Conversion of white to brown was 
monitored by UCP1 mRNA expression. Data are mean ± SEM. n.s. = not significant; 





Figure 3.20. Similar expression of pan-adipocyte genes after 6 weeks adipogenic 
induction with different induction protocols. bmMSCs were subjected for 6 weeks to 
either a white or brown protocol in the presence or absence of MMC. A third group of 
cultures was subjected to a white or brown protocol for 3 weeks and then switched to MMC 
or a brown protocol with MMC. LEP and FABP4 mRNA expression were measured. Data are 




3.5 MMC enhances adipogenic differentiation towards a brown adipocyte 
phenotype of progenitor cells isolated from the stromal vascular fraction (SVF) of 
abdominal subcutaneous fat 
So far I have shown that MMC enhanced brown adipogenesis in bmMSCs. I wanted 
to investigate whether MMC using sucrose co-polymer Ficoll also enhanced brown 
adipogenesis of other renewable adult progenitor cell sources which have a brown 
adipogenic potential. Subcutaneous white adipose tissue has shown browning 
capabilities under certain induction conditions (Schulz et al., 2011). Hence I obtained 
progenitor cells from the SVF of human abdominal subcutaneous fat as a kind gift 
from Dr Sue-Anne Toh and subjected them to the 3-week induction protocols ±MMC 
and measured UCP1 mRNA expression. The SVFs underwent adipogenesis at the end 
of the 3-week induction, with the appearance of intracellular lipid droplets in the 
induced conditions (Fig. 3.21). In terms of UCP1 expression, a similar trend was 
observed for this cell type (Fig. 3.22) as in the case of bmMSCs (refer to Fig. 3.1), 
where regardless of induction protocol used, MMC enhanced UCP1 expression. 
UCP1 was increased significantly by 30-fold in the ib mmc protocol compared to the 




Figure 3.21. SVF-derived adipocytes after a 3-week induction with a white (iw) 
or brown (ib) cocktail ± MMC. Phase contrast images taken at 4X magnification showed 
the change in cell morphology from spindle-like to round and the accumulation of lipid 
droplets. Scale bar: 500µm. 
 
 
Figure 3.22. MMC enhances UCP1 expression in adipocytes differentiated from 
subcutaneous abdominal SVF-derived progenitors. Progenitor cells isolated from the SVF 
of subcutaneous abdominal adipose tissue were chemically induced with a white (iw) or 
brown (ib) protocol ±MMC for 3 weeks and qPCR for UCP1 was carried out to assess brown 
adipogenesis. Raw Ct values of UCP1 are reported beside the graph. Data are mean ± SEM. 
n.s. = not significant; *p<0.05; **p<0.01; ***p<0.001.   
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3.6 Ficoll is taken up by bmMSC-derived ib mmc adipocytes, suggesting a MMC-
independent mechanism of enhancing brown adipocyte differentiation 
So far I have assumed that the sucrose co-polymer Ficoll enhances brown adipogenic 
differentiation by MMC which leads to an increased matrix deposition and an 
enriched lineage-directing extracellular microenvironment. However, my laboratory 
has discovered recently that Ficoll can be taken up by undifferentiated bmMSCs and 
shows co-localisation with the mitochondria (Rashid et al., 2014a). Hence I sought to 
investigate whether both Ficoll species Fc70 and Fc400, are also taken up by 
bmMSC-derived adipocytes. iw and ib mmc- generated adipocytes were incubated 
with TRITC-labelled Fc70 or Fc400 for 1h and co-stained with mitotracker Green 
before confocal imaging. Compared to TRITC-alone controls, the uptake of Fc70 and 
Fc400 in iw-generated adipoyctes was not substantial, although Fc400 showed 
slightly more uptake into the cells (Fig. 3.23). For the ib mmc-generated adipocytes, 
uptake of Fc400 was substantially higher compared to Fc70 and TRITC alone (Fig. 
3.24). Interestingly, Fc400 showed co-localisation with the mitotracker Green 
staining in the ib mmc-generated adipocytes, and also, to a lesser extent, in the iw-





Figure 3.23. Assessment of Ficoll uptake and mitochondrial co-localisation in 
bmMSC-derived white (iw) adipocytes. Differentiated iw adipocytes were incubated 
with TRITC-labelled Ficoll70 or Ficoll400 and co-stained with mitotracker green. Confocal 
images of bright field (BF), mitochondria (mito. G), and TRITC-labelled Ficoll (TRITC) to 
assess its uptake into bmMSC-derived adipocytes. TRITC alone was used as a control. Scale 





Figure 3.24. Assessment of Ficoll uptake and mitochondrial co-localisation in 
bmMSC-derived brown adipocytes generated under MMC (ib mmc). 
Differentiated ib mmc adipocytes were incubated with TRITC-labelled Ficoll70 or Ficoll400 
and co-stained with mitotracker green. Confocal images of bright field (BF), mitochondria 
(mito. G), and TRITC-labelled Ficoll (TRITC) to assess Ficoll uptake into bmMSC-derived 
adipocytes. TRITC alone was used as a control. Scale bar: 10µm. Experiment performed 
together with Dr. Rafi Rashid, NUS.  
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CHAPTER 4: DISCUSSION 
 
4.1 Validation of hypotheses and their implications 
In this study, I have confirmed hypotheses 1 & 2 that human adult bone marrow 
mesenchymal stem cells (bmMSCs) possess the intrinsic potential to differentiate into 
functional brown adipocytes, and this potential is greatly augmented with the addition 
of Ficoll during adipogenic induction (refer to Introduction section 1.10). This 
knowledge gained provides insight to a fundamental question in literature concerning 
the identity of adult human bone marrow fat and presents a functional human brown 
adipocyte progenitor cell source comparable with other human brown adipocyte 
differentiation models. While there is evidence to support hypothesis 3 that Ficoll 
enhances the native brown adipocyte phenotype of bmMSCs via the macromolecular 
crowding (MMC) effect of generating a richer lineage-directing microenvironment, 
the fact that Ficoll is taken up by the bmMSC-derived adipocytes suggests that Ficoll 
may also promote brown adipogenesis by other means besides MMC. Lastly, this 
novel adipogenic differentiation method also upregulates UCP1 expression of another 
sustainable progenitor cell type and thus opens up possibilities for therapeutic 






4.2 Yellow fat in bone marrow takes on a new meaning: presence of a population of 
brown fat in the bone marrow 
Bone marrow provides an environmental niche for haematopoiesis and bone. Fat is a 
major component of the bone marrow. In contrast to extramedullar fat depots, the 
type of fat and its function are largely unknown (Lecka-Czernik, 2012; Motyl and 
Rosen, 2011). Initially referred to as yellow adipose tissue, this depot was considered 
for a long time to occupy the space in bones no longer needed for hematopoiesis. 
However, research over the years have shown that marrow fat play a role in 
regulating haematopoiesis (Gimble et al., 2006; Naveiras et al., 2009) and possibly 
osteogenesis and systemic energy metabolism (Lecka-Czernik, 2012). Bone marrow 
fat has also been suspected to harbour a mixed white and brown fat phenotype (Calo 
et al., 2010; Gimble and Nuttall, 2004; Krings et al., 2012; Nishio et al., 2012; 
Olmsted-Davis et al., 2007). Although bone marrow mesenchymal stem cells 
(bmMSCs) give rise to bone, fat and supporting hematopoietic stroma (Minguell et 
al., 2001), whether they differentiate to both white and brown fat populations remains 
uncertain. Adult human bmMSCs have been shown to differentiate only into white 
adipocytes (Mackay et al., 2006). However, more recently some isolates of foetal 
bmMSCs have been found to differentiate into white adipocytes and others into 
brown albeit under identical induction conditions (Morganstein et al., 2010), showing 
an intrinsic potential in foetal bmMSCs to differentiate into brown adipocytes. 
Further, adenovirus-mediated overexpression of PGC1α in adult bmMSCs from a 
single donor yielded a modest 4-fold increase in UCP1 mRNA expression and a 2-
fold increase in mitochondrial mass and oxygen consumption after subjecting the 
transduced cells to adipogenic induction for 6 days (Huang et al., 2011),  although I 
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am sceptical that a late functional marker like UCP1 could be detected at such an 
early stage (6 days) of adipogenic differentiation for bmMSCs. 
My findings reveal that there is an intrinsic potential in adult human bmMSCs 
to differentiate towards a brown fat phenotype without genetic manipulation, and it 
was made possible only through the addition of Ficoll during the adipogenic 
induction period. In our protocol, neither a standard white nor a brown induction 
protocol significantly induced expression of UCP1 mRNA in bmMSCs. However, 
this changed dramatically when the sucrose co-polymer Ficoll was introduced into the 
cell cultures during adipogenic differentiation. UCP1 expression levels showed a 
substantial boost in the brown induction protocol (including forskolin stimulation of 
up to 800-fold), as well as in the white induction protocol. I attempted to define the 
bmMSC-derived brown adipocyte population, in comparison with bmMSC-derived 
white adipocytes, using a gene marker panel that distinguishes white, beige and 
classical brown adipocytes which has been recently validated in humans (refer to 
Introduction section 1.6). The UCP1-positive adipocytes however did not show an 
upregulation of other classical brown or beige markers or a downregulation of white 
marker HOXC9. The only difference was for the beige marker CD137, which was 
markedly downregulated in the UCP1-positive adipocytes. Moreover, raw Ct values 
for the beige markers were low (Ct > 31) and may not be biologically relevant in 
bmMSC-derived adipocytes. However, as the markers for classical brown and beige 
adipocytes have been characterized using cells from various adipose tissue depots and 
not from bone marrow, it cannot be ruled out that bmMSC-derived white adipocytes 
that were used as the baseline for comparison have a molecular signature different 
from subcutaneous WAT that has been traditionally used as the benchmark of white 
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adipocytes. For future work the brown adipocyte population from bone marrow 
would need to be compared against this benchmark. 
 
4.3 Comparability with other human brown adipocyte differentiation models 
This study shows that adult human bmMSCs can be differentiated into a functional 
brown adipocyte phenotype without genetic manipulation, as characterised by 
induction and high expression of UCP1, increased mitochondrial depolarisation, 
oxygen consumption and uncoupled respiration upon forskolin stimulation. I do have 
western blot data showing the presence of UCP1 protein in ib mmc-induced 
adipocytes, but there were issues with specificity of the antibodies used (Supp. Fig. 
2). More importantly, I have shown that ib mmc-induced adipocytes are functional 
brown adipocytes, indicated by a substantial increase in thermogenic genes, oxygen 
consumption and uncoupled respiration when thermogenesis was stimulated in these 
cells. 
The efficacy of differentiation (defined as the level of UCP1 expression 
benchmarked against a white differentiation protocol) in this cell model is superior to 
adult human bmMSC-derived adipocytes overexpressing PGC1α (4-fold) (Huang et 
al., 2011), and is comparable to other human cell models aiming at brown adipocyte 
differentiation that were discussed in Introduction section 1.8 (Table 1.5) including 
induced pluripotent cells (iPS) cells (20-fold) (Ahfeldt et al., 2012; Nishio et al., 
2012), human multipotent adipose-derived stem cells (hMADS) isolated from young 
donors (13-39 fold) (Elabd et al., 2009; Pisani et al., 2011) and even to those seen in 
preadipocytes from the subclavicular region in human adults (20-40 fold) (Lee et al., 
2011b). I am unable to compare our efficacy of differentiation with the recent 
publication on using brown adipose tissue derived stem cells from the mediastinum as 
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the authors did not report a fold change for UCP1 mRNA (Silva et al., 2014). From 
the cell models discussed here, there are currently only 3 sources (hMADS, 
supraclavicular fat, mediastinal fat) of human brown fat progenitors that do not utilise 
genetic manipulation and hence are good candidates for cellular therapy and research. 
In comparison to these 3 sources, our method of generating adult human brown 
adipocytes is more advantageous as our cell source is autologous (unlike the 
hMADS), easily obtainable in sustainable numbers (unlike supraclavicular and 
mediastinal fat) and yet allows for a robust differentiation response (Fig. 4.1). I, 
together with my lab members have in fact used 3 different lots of bmMSCs with 
predictable and stable results of at least 20 differentiation rounds (verified together 
with Anna Goralczyk, Xiu Min Ang, Rókus Kriszt and Jarrod Sim, NUS). 
 
 
Figure 4.1. Sources of human brown fat progenitors. Of the 3 current sources for 
human BAT progenitor cells that do not require genetic manipulation (left panel) all are 
exhaustible, and 2 require involved surgery for harvest. On the other hand, our proposed bone 
marrow source (right panel) is autologous and easily obtainable in sustainable numbers.  
[Image showing the supraclavicular and mediastinal fat locations was reprinted from Cell 
Metabolism, vol.11, Enerbäck S., “Human Brown Adipose Tissue”, p248-252, Copyright 




4.4 Browning of bmMSC-derived white adipocytes with Ficoll 
One of the most significant findings in this study is that Ficoll also encourages the 
conversion of bmMSC-derived white adipocytes into a brown phenotype (16-fold 
increase in UCP1 expression without genetic manipulation) which is comparable to 
the only other white-to-brown conversion model in humans using hMADS-derived 
adipocytes using a PPARγ agonist (15-28 fold) (Elabd et al., 2009; Pisani et al., 
2011). This suggests that the bmMSC-derived adipocytes either retain the plasticity to 
transdifferentiate from white adipocytes to a population of UCP1-expressing brown 
adipocytes, or the bmMSCs comprise a mixed population of white and brown 
progenitors where under conditions emulated by Ficoll, favour the differentiation of 





Figure 4.2. Browning of bmMSC-derived white adipocytes with Ficoll. Ficoll 
causes the browning of bmMSC-derived white adipocytes either by de novo recruitment of 
brown adipocyte stem cell progenitors, or a transdifferentiation of white adipocytes into 




4.5 MMC effects of Ficoll in enhancing brown adipocyte differentiation via the 
matrix 
Ficoll has been identified as an ideal candidate for macromolecular crowding (MMC) 
(Ellis, 2001) due to its comparable size (50-500kDa) with native macromolecules 
(e.g. albumin at 69kDa) in biological systems, neutral charge and low viscosity when 
dissolved in culture medium. In this study, I have used a crowding protocol using a 
mixture of Ficoll70 (Fc70) and Ficoll400 (Fc400) to create fraction volume 
occupancy of ~17% in the culture medium, thereby emulating the crowdedness of the 
perfused bone marrow compartment (Chen et al., 2011). Through the principle of 
excluded volume effect (EVE), MMC increases extracellular enzymatic reaction rates 
(refer to Introduction section 1.9), which result in increased ECM deposition and 
remodelling.  
In support of the hypothesis that Ficoll augments brown adipogenesis in adult 
human bmMSCs via the macromolecular crowding (MMC) effect of generating a 
richer lineage-directing microenvironment and driving bmMSC-derived adipocytes 
towards a mature adipocyte phenotype, my data show that along with an enriched 
ECM, there was a greater accumulation of lipid droplets, indicative of a more mature 
phenotype. It has been reported that under MMC, bmMSCs also increase in 
proliferation presumably due to a richer microenvironment deposited (Chen et al., 
2011). Thus, it is not unexpected that MMC increased cell density of our cultures 
observed in the phase contrast images after 3 weeks. This increased cell density due 
to the proliferation of non-differentiated cells residing in the adipocyte cultures 
generated under MMC might also contribute to a more efficient differentiation and 
attainment of a more mature phenotype as a high cell density favours adipogenic 
differentiation (McBeath et al., 2004).  
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To account for the enhanced ‘browning’ effect of MMC I initially considered 
that enhanced sequestration of fibroblast growth factors (FGFs) (Turner and Grose, 
2010) previously implicated in brown adipogenesis, might be promoted by the richer 
heparin sulphate proteoglycans (HSPG) deposited under MMC (my data, (Ang et al., 
2014)). While I found no evidence of FGF21 expression, a notable browning factor 
(Fisher et al., 2012), I retrieved both FGF1 and 2 protein from salt-washed cell layers 
of bmMSC-derived adipocyte cultures at levels exceeding human serum 
concentrations by two orders of magnitude (Larsson et al., 2002). However, the 
amount of FGF eluted did not differ significantly between MMC and non-MMC 
cultured adipocytes. This is in contrast with a several fold increase in deposition of 
perlecan (HSPG2) in our cultures, a proteoglycan known for its ability to store FGF1 
(Melrose et al., 2006) and FGF2 (Jiang and Couchman, 2003). It could be possible 
that although the MMC-generated matrices have a higher capacity to sequester FGFs, 
there may have been an increased ECM depletion of FGF, given that FGF2 bound to 
perlecan HS-chains can be released very efficiently by matrix metalloproteinases 
(Whitelock et al., 1996). As MMC-driven adipogenesis features extensive matrix 
remodelling and associated MMP activity (Ang et al., 2014), such a scenario is 
plausible. Besides FGFs, HSPG binds other growth factors including members of the 
epidermal growth factor (EGF) family (Taipale and Keski-Oja, 1997). It has been 
reported recently that several members of the EGF family such as betacellulin, 
heparin-binding EGF-like growth factor, epiregulin and parathyroid-hormone-related 
protein induced Ucp1 mRNA levels in murine primary adipocytes (Kir et al., 2014), 
hence it would be worthwhile to investigate the amount of these growth factors 
sequestered in the ECM generated by MMC. 
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It is possible that collagen IV, whose deposition is enhanced by MMC, is 
responsible for the increased sequestration of other growth factors which promote 
brown adipocyte differentiation. BMP7, a strong inductor of BAT, has recently been 
predicted to be sequestered into the ECM (Gregory et al., 2005). Furthermore, as 
collagen IV is known to bind BMPs such as BMP4 (Wang et al., 2008b), it is 
tempting to speculate that a higher amount of BMP7 is sequestered in the ECM 
generated under MMC and thus would explain the strong browning effects of MMC 
in the absence of exogenous BMP7. Another BMP candidate to investigate would be 
BMP4, which has been found to induce browning in murine beige but not classical 
brown adipocytes (Qian et al., 2013). 
Besides sequestration of growth factors, the niche-specific composition and 
structure of the ECM influence the behaviour of bmMSCs through focal adhesions 
where integrin receptors interact with various ECM proteins and initiate a signalling 
cascade to regulate differentiation towards a particular cell fate (Docheva et al., 
2007). In our study I found ITGA2 significantly downregulated in adipocytes induced 
with MMC, indicative of a more adipogenic phenotype (Frith et al., 2012; Ullah et al., 
2013). While there are no detailed reports of downstream integrin signalling effects in 
brown adipogenesis, our finding with ITGA2 suggests that the ECM composition and 
structure generated under MMC enable bmMSCs to undergo adipogenic 
differentiation to a greater extent and exhibit its intrinsic brown potential. Other 
integrins involved in adipogenesis include integrins α6 (Frith et al., 2012) and α5 (Liu 





4.6 Possible non-MMC effect of Ficoll in enhancing brown adipocyte 
differentiation 
Mechanical stress due to osmotic challenge in cells have a profound effect on cell 
proliferation and differentiation. The forces produced are sensed by mechanosensitive 
channels which will translate these signals into biochemical signaling cascades to 
effect a cellular response (Blount et al., 2008; Niisato and Marunaka, 2008). Ficoll is 
a high molecular weight sucrose co-polymer formed by the co-polymerisation of 
sucrose with epichlorohydrin (Fig. 4.3). (Blount et al., 2008; Niisato and Marunaka, 
2008). Ficoll is taken up by bmMSCs via pinocytosis and is broken down into smaller 
fragments at intralysosomal acidic pH 4.8 (Dr. Rafi Rashid’s thesis; (Rashid et al., 
2014a)). A possible scenario upon Ficoll uptake in the cells via endocytosis is that 
Ficoll is broken down into sucrose upon the decrease in luminal pH when endosomes 
mature into lysosomes, which in turn increases the luminal concentration leading to 
an influx of water into the lysosomes. Hypo-osmotic pressure stretches membranes 
and activate transient receptor potential (TRP) channels, a type of mechanosensitive 
channel (Gomis et al., 2008). TRP channels such as transient receptor potential 
vanilloid-4 (TRPV4) and transient receptor potential melastin 8 (TRPM8) regulate 
brown adipogenesis (Villarroya and Vidal-Puig, 2013). TRP channels are present in 
endosomes and lysosomes, and are involved in endosomal pathway signalling by 
regulating the release of Ca2+ from endosomes and lysosomes (Abe and Puertollano, 
2011). There is increasing evidence for endosomes serving as a signalling entities for 
crosstalk between cellular pathways (Palfy et al., 2012). In the Results section 3.6, I 
have shown that Ficoll was taken up by bmMSC-derived adipocytes, which may lead 
to intra-lysosomal hypotonic stress and the activation of lysosomal TRPs that enhance 




Figure 4.3. Components of Ficoll. Ficoll is manufactured by the co-polymerisation of 
sucrose monomers with epichlorohydrin linkages. (Chemical structure drawings were made 
using a web-based software: http://web.chemdoodle.com/demos/sketcher) 
 
 
4.7 Ficoll enhances brown adipogenesis of another adult cell source from 
subcutaneous white adipose tissue 
Preliminary data show that Ficoll enhanced the expression of UCP1 significantly by 
30-fold in adipocytes differentiated using a brown induction protocol from 
progenitors isolated from the stromal vascular fraction of the subcutaneous abdominal 
white adipose tissue as compared to a white induction protocol alone. This is an 
exciting finding as subcutaneous abdominal fat would pose as an ideal autologous cell 
source for obesity therapy as obese patients would be more willing to have their 





CHAPTER 5: CONCLUSION AND FUTURE OUTLOOK 
 
I report for the first time of the generation of functional brown adipocytes from adult 
human bone marrow mesenchymal stem cells (bmMSCs) without the need for genetic 
manipulation, using Ficoll as a cell culture additive to unlock the intrinsic browning 
potential of bmMSCs. Ficoll enhances brown adipogenesis probably through the 
MMC effect of increasing matrix deposition and generating a richer lineage-directing 
matrix which promotes adipogenic differentiation to a more mature phenotype; but a 
non-MMC effect whereby upon uptake by the cells could increase intra-luminal 
hypo-osmotic stress and activate mechanosensitive channels which promotes brown 
adipogenesis in the cells is also plausible. 
I believe that our data support exciting new opportunities for isolating and 
manipulating bmMSCs as a robust, autologous and sustainable source of human 
brown adipocytes. Moreover, I have preliminary data to show that subcutaneous 
adipose tissue is another potential renewable adult cell source of which Ficoll also 
enhances the intrinsic browning potential. Investing time and resources to further 
elucidate the mechanism of Ficoll in enhancing brown adipogenesis would be useful 
to better understand our system, which has promising translational applications in the 
fields of obesity and metabolic disorders. I hope to use these cells to develop an in 
vitro screening platform to identify agents that promote brown adipogenesis, as well 
as agents that stimulate the thermogenic programme in functional brown adipocytes. I 
would also like to conduct in vivo transplantation studies of our generated brown 
adipocytes into an animal model as a pre-clinical study of efficacy to explore the 
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Supplementary figure 1. hbmMSC-generated adipocytes also produced fine Col 
IV fibres under the brown induction (ib) protocol without MMC. Z-project image 
of DAPI (blue), Col IV (red) and BODIPY (green). Scale bar: 20µm. Experiment performed 
together with Anna Goralczyk, Rókus Kriszt, Jean-Yves Dewavrin, NUS; and Dr. Cedric 






Supplementary figure 2. Use of commercial antibodies to detect UCP1 protein in 
bmMSC-derived adipocytes. (A) Western blot of bmMSC-derived adipocytes for UCP1 
and β-actin. bmMSCs were differentiated into adipocytes with a white (iw) or brown +MMC 
(ib mmc) induction protocol for 3 weeks. Non-induced cells were cultured in maintenance 
medium ±MMC as a control. Cells were then treated with 4h 10µM forskolin (forsk) or 
vehicle (DMSO). UCP1 antibody used was ab10983 (Abcam). Despite the presence of a 
~50kDa band throughout all samples, probably due to the naturally occurring antibodies to 
keratin in rabbit sera (Osborn et al., 1977), a ~32kDa band was detected only in the ib mmc 
samples. (B) bmMSCs were chemically induced into adipocytes with a white (iw) or brown 
(ib) induction protocol ±MMC for 3 weeks. Non-induced cells were cultured in maintenance 
medium ±MMC as a control. Presence of UCP1 was determined by immunocytochemistry. 
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